Does	O
activation	O
of	O
the	O
TAL1	B-DNA
gene	I-DNA
occur	O
in	O
a	O
majority	O
of	O
patients	O
with	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
?	O
A	O
pediatric	O
oncology	O
group	O
study	O
.	O

Almost	O
25	O
%	O
of	O
patients	O
with	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T-ALL	O
)	O
have	O
tumor-specific	O
rearrangements	O
of	O
the	O
TAL1	B-DNA
gene	I-DNA
.	O

Although	O
TAL1	B-protein
expression	O
has	O
not	O
been	O
observed	O
in	O
normal	B-cell_type
lymphocytes	I-cell_type
,	O
TAL1	B-protein
gene	I-protein
products	I-protein
are	O
readily	O
detected	O
in	O
leukemic	B-cell_type
cells	I-cell_type
that	O
harbor	O
a	O
rearranged	B-DNA
TAL1	I-DNA
allele	I-DNA
.	O

Hence	O
,	O
it	O
has	O
been	O
proposed	O
that	O
ectopic	O
expression	O
of	O
TAL1	B-protein
promotes	O
the	O
development	O
of	O
T-ALL	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
TAL1	B-protein
is	O
expressed	O
in	O
the	O
leukemic	B-cell_type
cells	I-cell_type
of	O
most	O
patients	O
with	O
T-ALL	O
,	O
including	O
many	O
that	O
do	O
not	O
display	O
an	O
apparent	O
TAL1	B-DNA
gene	I-DNA
alteration	O
.	O

A	O
polymorphic	O
dinucleotide	O
repeat	O
in	O
the	O
transcribed	O
sequences	O
of	O
TAL1	B-protein
was	O
used	O
to	O
determine	O
the	O
allele	O
specificity	O
of	O
TAL1	B-protein
transcription	O
in	O
primary	B-cell_type
T-ALL	I-cell_type
cells	I-cell_type
.	O

Monoallelic	O
expression	O
of	O
TAL1	B-protein
was	O
observed	O
in	O
the	O
leukemic	B-cell_type
cells	I-cell_type
of	O
all	O
patients	O
(	O
8	O
of	O
8	O
)	O
bearing	O
a	O
TAL1	B-DNA
gene	I-DNA
rearrangement	O
.	O

In	O
the	O
leukemic	B-cell_type
cells	I-cell_type
of	O
patients	O
without	O
detectable	O
TAL1	B-protein
rearrangements	O
,	O
TAL1	B-protein
transcription	O
occurred	O
in	O
either	O
a	O
monoallelic	O
(	O
3	O
of	O
7	O
patients	O
)	O
or	O
a	O
biallelic	O
(	O
4	O
of	O
7	O
patients	O
)	O
fashion	O
.	O

Thus	O
,	O
TAL1	B-protein
activation	O
in	O
these	O
patients	O
may	O
result	O
from	O
subtle	O
alterations	O
in	O
cis-acting	B-DNA
regulatory	I-DNA
sequences	I-DNA
(	O
affecting	O
expression	O
of	O
a	O
single	B-DNA
TAL1	I-DNA
allele	I-DNA
)	O
or	O
changes	O
in	O
trans-acting	O
factors	O
that	O
control	O
TAL1	B-protein
transcription	O
(	O
affecting	O
expression	O
of	O
both	O
TAL1	B-DNA
alleles	I-DNA
)	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Does	NULL
Activation	NULL
of	NULL
the	NULL
TAL	NULL
]	NULL
Gene	NULL
Occur	NULL
in	NULL
a	NULL
Majority	NULL
of	NULL
Patients	NULL
With	NULL
T-Cell	NULL
Acute	NULL
Lymphoblastic	NULL
Leukemia	NULL
?	NULL

A	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
Study	NULL
By	NULL
Robert	NULL
0	NULL
.	NULL

Bash	NULL
,	NULL
Shirley	NULL
Hail	NULL
,	NULL
Charles	NULL
F.	NULL
Timmons	NULL
,	NULL
William	NULL
M.	NULL
Crist	NULL
,	NULL
Michael	NULL
Amylon	NULL
,	NULL
R.	NULL
Graham	NULL
Smith	NULL
,	NULL
and	NULL
Richard	NULL
Baer	NULL
Almost	NULL
25	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
T-ALL	NULL
)	NULL
have	NULL
tumor-specific	NULL
rearrangements	NULL
of	NULL
the	NULL
TAL1	NULL
gene	NULL
.	NULL

Although	NULL
TAL	NULL
?	NULL

expression	NULL
has	NULL
not	NULL
been	NULL
observed	NULL
in	NULL
normal	NULL
lymphocytes	NULL
,	NULL
TALT	NULL
gene	NULL
products	NULL
are	NULL
readily	NULL
detected	NULL
in	NULL
leukemic	NULL
cells	NULL
that	NULL
harbor	NULL
a	NULL
rearranged	NULL
TAL	NULL
1	NULL
allele	NULL
.	NULL

Hence	NULL
,	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
ectopic	NULL
expression	NULL
of	NULL
TAL1	NULL
promotes	NULL
the	NULL
development	NULL
of	NULL
T-ALL	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
TAL1	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
most	NULL
patients	NULL
with	NULL
T-ALL	NULL
,	NULL
including	NULL
many	NULL
that	NULL
do	NULL
not	NULL
display	NULL
an	NULL
apparent	NULL
TALT	NULL
gene	NULL
alteration	NULL
.	NULL

A	NULL
polymorphic	NULL
dinucleotide	NULL
repeat	NULL
in	NULL
the	NULL
transcribed	NULL
sequences	NULL
of	NULL
TAL1T	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
allele	NULL
specificity	NULL
of	NULL
TALT	NULL
tran	NULL
ERTAIN	NULL
HEMATOPOIETIC	NULL
malignancies	NULL
are	NULL
characterized	NULL
by	NULL
tumor-specific	NULL
chromosome	NULL
defects	NULL
that	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
a	NULL
vast	NULL
majority	NULL
of	NULL
the	NULL
affected	NULL
patients	NULL
.	NULL

The	NULL
Philadelphia	NULL
chromosome	NULL
is	NULL
a	NULL
seminal	NULL
example	NULL
;	NULL
this	NULL
cytogenetic	NULL
defect	NULL
arises	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
(	NULL
9	NULL
;	NULL
22	NULL
)	NULL
(	NULL
q34	NULL
;	NULL
q11	NULL
)	NULL
translocation	NULL
in	NULL
nearly	NULL
85	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
.	NULL
'	NULL

''	NULL
Similarly	NULL
,	NULL
the	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q24	NULL
;	NULL
q32	NULL
)	NULL
translocation	NULL
is	NULL
found	NULL
in	NULL
more	NULL
than	NULL
85	NULL
%	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
patients	NULL
,	NULL
and	NULL
the	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
(	NULL
q32	NULL
;	NULL
q21	NULL
)	NULL
translocation	NULL
occurs	NULL
in	NULL
over	NULL
80	NULL
%	NULL
of	NULL
patients	NULL
afflicted	NULL
with	NULL
follicular	NULL
B-cell	NULL
lymphoma	NULL
.	NULL
``	NULL

Significantly	NULL
,	NULL
each	NULL
of	NULL
these	NULL
chromosome	NULL
abnormalities	NULL
causes	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
particular	NULL
proto-oncogene	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q24	NULL
;	NULL
q32	NULL
)	NULL
translocation	NULL
results	NULL
in	NULL
juxtaposition	NULL
of	NULL
the	NULL
MYC	NULL
gene	NULL
from	NULL
chromosome	NULL
8	NULL
with	NULL
sequences	NULL
from	NULL
the	NULL
Ig	NULL
locus	NULL
on	NULL
chromosome	NULL
14	NULL
.	NULL

The	NULL
translocated	NULL
allele	NULL
of	NULL
MYC	NULL
is	NULL
thereby	NULL
activated	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
presumably	NULL
promotes	NULL
the	NULL
formation	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

Because	NULL
most	NULL
patients	NULL
with	NULL
this	NULL
disease	NULL
harbor	NULL
the	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q24	NULL
;	NULL
q32	NULL
)	NULL
translocation	NULL
,	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
;	NULL
St	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
and	NULL
The	NULL
University	NULL
of	NULL
Tennessee	NULL
,	NULL
Memphis	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
;	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
;	NULL
and	NULL
the	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
.	NULL

Submitted	NULL
February	NULL
7	NULL
,	NULL
1995	NULL
;	NULL
February	NULL
23	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
(	NULL
CA46593	NULL
)	NULL
.	NULL

Also	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Children	NULL
's	NULL
Cancer	NULL
Fund	NULL
of	NULL
Dallas	NULL
,	NULL
the	NULL
American	NULL
Lebanese	NULL
Syrian	NULL
Associated	NULL
Charities	NULL
and	NULL
by	NULL
Grants	NULL
No	NULL
.	NULL

CA30969	NULL
,	NULL
CA33265	NULL
,	NULL
CA33603	NULL
,	NULL
CA31566	NULL
,	NULL
and	NULL
CA21765	NULL
(	NULL
CORE	NULL
)	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
.	NULL

R.O.B	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
an	NULL
American	NULL
Society	NULL
of	NULL
Clinical	NULL
Oncology	NULL
Young	NULL
Investigator	NULL
Award	NULL
.	NULL

RB	NULL
.	NULL

is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Simmons	NULL
Arthritis	NULL
Research	NULL
Center	NULL
and	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
Faculty	NULL
Research	NULL
Award	NULL
from	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
(	NULL
FRA-421	NULL
)	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Richard	NULL
Baer	NULL
,	NULL
PhD	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
5323	NULL
Harry	NULL
Hines	NULL
Blvd	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
75235-9048	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
'*advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/95/8602-0040	NULL
$	NULL
3.00/0	NULL
666	NULL
scription	NULL
in	NULL
primary	NULL
T-ALL	NULL
cells	NULL
.	NULL

Monoallelic	NULL
expression	NULL
of	NULL
TAL1	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
all	NULL
patients	NULL
(	NULL
8	NULL
of	NULL
8	NULL
)	NULL
bearing	NULL
a	NULL
TAL	NULL
T	NULL
gene	NULL
rearrangement	NULL
.	NULL

In	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
without	NULL
detectable	NULL
TAL1T	NULL
rearrangements	NULL
,	NULL
TAL	NULL
!	NULL

transcription	NULL
occurred	NULL
in	NULL
either	NULL
a	NULL
monoallelic	NULL
(	NULL
3	NULL
of	NULL
7	NULL
patients	NULL
)	NULL
or	NULL
a	NULL
biallelic	NULL
(	NULL
4	NULL
of	NULL
7	NULL
patients	NULL
)	NULL
fashion	NULL
.	NULL

Thus	NULL
,	NULL
TALT	NULL
activation	NULL
in	NULL
these	NULL
patients	NULL
may	NULL
result	NULL
from	NULL
subtle	NULL
alterations	NULL
in	NULL
cis-acting	NULL
regulatory	NULL
sequences	NULL
{	NULL
affecting	NULL
expression	NULL
of	NULL
a	NULL
single	NULL
TAL1	NULL
allele	NULL
}	NULL
or	NULL
changes	NULL
in	NULL
trans-acting	NULL
factors	NULL
that	NULL
control	NULL
TAL1	NULL
transcription	NULL
(	NULL
affecting	NULL
expression	NULL
of	NULL
both	NULL
TALT	NULL
al-leles	NULL
}	NULL
.	NULL

Â©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

MYC	NULL
activation	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
a	NULL
critical	NULL
,	NULL
if	NULL
not	NULL
essential	NULL
,	NULL
step	NULL
in	NULL
the	NULL
development	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
distinct	NULL
chromosome	NULL
translocations	NULL
are	NULL
observed	NULL
in	NULL
the	NULL
malignant	NULL
cells	NULL
of	NULL
patients	NULL
with	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
T-ALL	NULL
)	NULL
.	NULL
``	NULL

At	NULL
least	NULL
nine	NULL
different	NULL
proto-oncogenes	NULL
are	NULL
activated	NULL
as	NULL
a	NULL
result	NULL
of	NULL
these	NULL
translocations	NULL
,	NULL
in	NULL
most	NULL
cases	NULL
by	NULL
juxtaposition	NULL
with	NULL
sequences	NULL
from	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
loci	NULL
on	NULL
chromosome	NULL
7	NULL
or	NULL
14	NULL
.	NULL
``	NULL

However	NULL
,	NULL
each	NULL
of	NULL
these	NULL
translocations	NULL
is	NULL
found	NULL
in	NULL
only	NULL
a	NULL
small	NULL
proportion	NULL
of	NULL
T-ALL	NULL
patients	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
most	NULL
prevalent	NULL
,	NULL
the	NULL
(	NULL
11	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q11	NULL
)	NULL
translocation	NULL
,	NULL
occurs	NULL
in	NULL
less	NULL
than	NULL
10	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
T-ALL	NULL
.	NULL

Consequently	NULL
,	NULL
molecular	NULL
studies	NULL
of	NULL
chromosome	NULL
translocations	NULL
have	NULL
failed	NULL
to	NULL
identify	NULL
a	NULL
common	NULL
genetic	NULL
defect	NULL
critical	NULL
for	NULL
the	NULL
development	NULL
of	NULL
T-ALL	NULL
.	NULL

The	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p34	NULL
;	NULL
q11	NULL
)	NULL
translocation	NULL
causes	NULL
juxtaposition	NULL
of	NULL
the	NULL
TALLI	NULL
gene	NULL
with	NULL
sequences	NULL
from	NULL
the	NULL
TCR	NULL
Â«	NULL
/d	NULL
chain	NULL
locus	NULL
.	NULL

*	NULL
``	NULL
Although	NULL
this	NULL
translocation	NULL
is	NULL
only	NULL
observed	NULL
in	NULL
approximately	NULL
3	NULL
%	NULL
of	NULL
T-ALL	NULL
patients	NULL
,	NULL
``	NULL
an	NULL
additional	NULL
25	NULL
%	NULL
of	NULL
patients	NULL
harbor	NULL
a	NULL
tumor-specific	NULL
rearrangement	NULL
of	NULL
TALZ	NULL
that	NULL
is	NULL
not	NULL
detected	NULL
cytogenetically	NULL
.	NULL

'*	NULL
``	NULL
*	NULL
This	NULL
rearrangement	NULL
arises	NULL
from	NULL
a	NULL
local	NULL
DNA	NULL
deletion	NULL
(	NULL
the	NULL
tal	NULL
``	NULL
recombination	NULL
)	NULL
that	NULL
removes	NULL
90	NULL
to	NULL
100	NULL
kbp	NULL
of	NULL
upstream	NULL
sequence	NULL
from	NULL
the	NULL
TAL	NULL
]	NULL
locus	NULL
.	NULL

Thus	NULL
,	NULL
TALI	NULL
rearrangement	NULL
,	NULL
whether	NULL
mediated	NULL
by	NULL
chromosome	NULL
translocation	NULL
or	NULL
by	NULL
tall	NULL
``	NULL
recombination	NULL
,	NULL
is	NULL
the	NULL
most	NULL
common	NULL
genetic	NULL
defect	NULL
known	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
The	NULL
presentation	NULL
features	NULL
and	NULL
clinical	NULL
outcomes	NULL
of	NULL
T-ALL	NULL
patients	NULL
who	NULL
have	NULL
TALI	NULL
gene	NULL
rearrangements	NULL
are	NULL
almost	NULL
indistinguishable	NULL
from	NULL
those	NULL
who	NULL
do	NULL
not	NULL
.	NULL
``	NULL

''	NULL
Therefore	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
patients	NULL
without	NULL
TAL	NULL
]	NULL
rearrangements	NULL
harbor	NULL
other	NULL
genetic	NULL
alterations	NULL
that	NULL
are	NULL
functionally	NULL
equivalent	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
TAL2	NULL
and	NULL
LYL1	NULL
genes	NULL
encode	NULL
presumptive	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
highly	NULL
related	NULL
to	NULL
the	NULL
protein	NULL
product	NULL
of	NULL
TALH	NULL
.	NULL
``	NULL

Because	NULL
TAL2	NULL
and	NULL
LYL1	NULL
are	NULL
also	NULL
activated	NULL
by	NULL
tumor-specific	NULL
chromosome	NULL
translocations	NULL
associated	NULL
with	NULL
T-ALL	NULL
,	NULL
these	NULL
genes	NULL
may	NULL
promote	NULL
leukemogenesis	NULL
in	NULL
a	NULL
manner	NULL
analogous	NULL
to	NULL
TAL	NULL
]	NULL
.	NULL

*	NULL
Nevertheless	NULL
,	NULL
chromosome	NULL
translocations	NULL
involving	NULL
TAL2	NULL
and	NULL
LYLI	NULL
are	NULL
uncommon	NULL
,	NULL
affecting	NULL
fewer	NULL
than	NULL
2	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
T-ALL	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
T-ALL	NULL
patients	NULL
,	NULL
perhaps	NULL
as	NULL
many	NULL
as	NULL
70	NULL
%	NULL
,	NULL
do	NULL
not	NULL
show	NULL
any	NULL
of	NULL
the	NULL
known	NULL
tumor-specific	NULL
alterations	NULL
of	NULL
the	NULL
TALI	NULL
,	NULL
TAL2	NULL
,	NULL
or	NULL
LYLI	NULL
genes	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
86	NULL
,	NULL
No	NULL
2	NULL
(	NULL
July	NULL
15	NULL
)	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
666-676	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ACTIVATION	NULL
OF	NULL
THE	NULL
TAL	NULL
!	NULL

GENE	NULL
The	NULL
rearranged	NULL
alleles	NULL
of	NULL
TAL1	NULL
are	NULL
readily	NULL
transcribed	NULL
in	NULL
T-ALL	NULL
cells	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
TALI	NULL
expression	NULL
has	NULL
not	NULL
been	NULL
observed	NULL
during	NULL
normal	NULL
T-cell	NULL
development	NULL
.	NULL

Therefore	NULL
,	NULL
tumor-specific	NULL
rearrangement	NULL
of	NULL
TAL	NULL
!	NULL

may	NULL
promote	NULL
leukemogenesis	NULL
by	NULL
inducing	NULL
ectopic	NULL
TAL1	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
T	NULL
lineage	NULL
.	NULL

We	NULL
now	NULL
report	NULL
that	NULL
TAL	NULL
]	NULL
transcripts	NULL
are	NULL
present	NULL
in	NULL
the	NULL
malignant	NULL
cells	NULL
of	NULL
most	NULL
patients	NULL
with	NULL
T-ALL	NULL
,	NULL
including	NULL
many	NULL
that	NULL
do	NULL
not	NULL
have	NULL
obvious	NULL
TALL	NULL
gene	NULL
alterations	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
malignant	NULL
activation	NULL
of	NULL
TALl	NULL
can	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
gross	NULL
structural	NULL
DNA	NULL
rearrangement	NULL
and	NULL
that	NULL
TALJ	NULL
activation	NULL
represents	NULL
a	NULL
major	NULL
pathway	NULL
in	NULL
the	NULL
development	NULL
of	NULL
T-ALL	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Patient	NULL
population	NULL
.	NULL

-	NULL
Samples	NULL
of	NULL
bone	NULL
marrow	NULL
(	NULL
BM	NULL
)	NULL
,	NULL
peripheral	NULL
blood	NULL
(	NULL
PB	NULL
)	NULL
or	NULL
pleural	NULL
fluid	NULL
(	NULL
PF	NULL
)	NULL
were	NULL
obtained	NULL
before	NULL
treatment	NULL
from	NULL
219	NULL
children	NULL
with	NULL
T-ALL	NULL
.	NULL

Sixty-five	NULL
of	NULL
these	NULL
specimens	NULL
were	NULL
sent	NULL
directly	NULL
to	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
(	NULL
Dallas	NULL
,	NULL
TX	NULL
)	NULL
from	NULL
the	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
(	NULL
POG	NULL
)	NULL
institution	NULL
treating	NULL
the	NULL
child	NULL
.	NULL

The	NULL
remainder	NULL
(	NULL
155	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
POG	NULL
Cell	NULL
Bank	NULL
at	NULL
St	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
(	NULL
Memphis	NULL
,	NULL
TN	NULL
)	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
confirmed	NULL
to	NULL
be	NULL
T-ALL	NULL
as	NULL
defined	NULL
by	NULL
blast	NULL
cell	NULL
surface	NULL
immunophe-notype	NULL
.	NULL
``	NULL

All	NULL
surface	NULL
marker	NULL
analyses	NULL
were	NULL
performed	NULL
(	NULL
or	NULL
re-viewed	NULL
)	NULL
by	NULL
Dr	NULL
M.	NULL
Link	NULL
(	NULL
Stanford	NULL
University	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
POG-wide	NULL
standardization	NULL
.	NULL

BM	NULL
samples	NULL
were	NULL
also	NULL
obtained	NULL
before	NULL
treatment	NULL
from	NULL
children	NULL
diagnosed	NULL
with	NULL
early	NULL
B-lineage	NULL
ALL	NULL
at	NULL
the	NULL
Children	NULL
's	NULL
Medical	NULL
Center	NULL
of	NULL
Dallas	NULL
.	NULL

All	NULL
leukemic	NULL
samples	NULL
were	NULL
enriched	NULL
for	NULL
lymphoblasts	NULL
by	NULL
Ficoll-Hypaque	NULL
centrifugation	NULL
``	NULL
**	NULL
and	NULL
frozen	NULL
as	NULL
described	NULL
for	NULL
Cell	NULL
Bank	NULL
specimens	NULL
``	NULL
or	NULL
directly	NULL
processed	NULL
for	NULL
DNA	NULL
and	NULL
RNA	NULL
.	NULL

Leukemic	NULL
samples	NULL
from	NULL
37	NULL
of	NULL
the	NULL
219	NULL
T-ALL	NULL
patients	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
TAL	NULL
]	NULL
gene	NULL
products	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Patients	NULL
no	NULL
.	NULL

1	NULL
through	NULL
18	NULL
were	NULL
selected	NULL
from	NULL
the	NULL
65	NULL
specimens	NULL
sent	NULL
directly	NULL
to	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
;	NULL
these	NULL
samples	NULL
were	NULL
chosen	NULL
based	NULL
solely	NULL
on	NULL
the	NULL
availability	NULL
of	NULL
an	NULL
adequate	NULL
supply	NULL
of	NULL
RNA	NULL
for	NULL
ribonuclease	NULL
protection	NULL
analysis	NULL
.	NULL

Patients	NULL
no	NULL
.	NULL

19	NULL
through	NULL
37	NULL
were	NULL
selected	NULL
from	NULL
the	NULL
155	NULL
POG	NULL
Cell	NULL
Bank	NULL
specimens	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
two	NULL
criteria	NULL
,	NULL
(	NULL
1	NULL
)	NULL
the	NULL
availability	NULL
of	NULL
RNA	NULL
and	NULL
(	NULL
2	NULL
)	NULL
heterozygosity	NULL
at	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
marker	NULL
of	NULL
TALI	NULL
.	NULL

Sufficient	NULL
material	NULL
from	NULL
32	NULL
of	NULL
the	NULL
37	NULL
samples	NULL
was	NULL
also	NULL
available	NULL
to	NULL
perform	NULL
a	NULL
manual	NULL
differential	NULL
count	NULL
of	NULL
the	NULL
nucleated	NULL
cells	NULL
after	NULL
Wright-Giemsa	NULL
staining	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Normal	NULL
control	NULL
samples	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
excess	NULL
PB	NULL
of	NULL
84	NULL
nonleukemic	NULL
individuals	NULL
after	NULL
diagnostic	NULL
testing	NULL
in	NULL
the	NULL
laboratories	NULL
of	NULL
Children	NULL
's	NULL
Medical	NULL
Center	NULL
of	NULL
Dallas	NULL
.	NULL

DNA	NULL
extraction	NULL
and	NULL
Southern	NULL
analysis	NULL
.	NULL

-	NULL
High	NULL
molecular	NULL
weight	NULL
DNA	NULL
was	NULL
extracted	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Southern	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
AA-0.6	NULL
and	NULL
B2EE-2.0	NULL
probes	NULL
to	NULL
detect	NULL
tumor-specific	NULL
TAL	NULL
]	NULL
gene	NULL
alterations	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

'*	NULL
``	NULL
'	NULL
RNA	NULL
extraction	NULL
and	NULL
ribonuclease	NULL
protection	NULL
assays	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
from	NULL
lymphoblasts	NULL
by	NULL
a	NULL
guanidinium-thiocyanate-phenol-chloroform	NULL
single-step	NULL
extraction	NULL
protocol	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
washed	NULL
with	NULL
70	NULL
%	NULL
ethanol	NULL
and	NULL
resuspended	NULL
in	NULL
diethyl	NULL
pyrocarbonate-treated	NULL
water	NULL
.	NULL

In	NULL
vitro	NULL
translation	NULL
of	NULL
the	NULL
tal1CB/pGEM4	NULL
plasmid	NULL
with	NULL
SP6	NULL
RNA	NULL
polymerase	NULL
(	NULL
Promega	NULL
,	NULL
Mad-ison	NULL
,	NULL
WI	NULL
)	NULL
yielded	NULL
a	NULL
P-labeled	NULL
RNA	NULL
probe	NULL
of	NULL
234	NULL
nucleotides	NULL
;	NULL
this	NULL
probe	NULL
includes	NULL
141	NULL
antisense	NULL
residues	NULL
that	NULL
span	NULL
the	NULL
exon	NULL
S5-exon	NULL
6	NULL
junction	NULL
of	NULL
The	NULL
quality	NULL
of	NULL
each	NULL
leukemic	NULL
RNA	NULL
sample	NULL
was	NULL
confirmed	NULL
using	NULL
a	NULL
*Â°P-labeled	NULL
RNA	NULL
probe	NULL
containing	NULL
103	NULL
antisense	NULL
nucleotides	NULL
of	NULL
the	NULL
human	NULL
glyceraldehyde-3-phosphate	NULL
dehydroge-nase	NULL
(	NULL
GADP	NULL
)	NULL
gene	NULL
;	NULL
the	NULL
probe	NULL
was	NULL
obtained	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
of	NULL
the	NULL
pGADP4/pGEMT7	NULL
plasmid	NULL
(	NULL
provided	NULL
by	NULL
Dr	NULL
F.G.	NULL
Kem	NULL
,	NULL
Georgetown	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Washington	NULL
,	NULL
DC	NULL
)	NULL
.	NULL

The	NULL
ra-diolabeled	NULL
RPA	NULL
probes	NULL
(	NULL
TAL1	NULL
and	NULL
GADP	NULL
)	NULL
were	NULL
annealed	NULL
simultane-	NULL
667	NULL
ously	NULL
to	NULL
10	NULL
ug	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
each	NULL
leukemic	NULL
sample	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
RNase	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
,	NULL
the	NULL
digestion	NULL
products	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
an	NULL
8	NULL
mol/L	NULL
urea	NULL
,	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
protected	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
repeat	NULL
polymorphism	NULL
.	NULL

-	NULL
The	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
was	NULL
performed	NULL
on	NULL
each	NULL
leukemic	NULL
DNA	NULL
sample	NULL
using	NULL
oligonucleotide	NULL
primers	NULL
PM2	NULL
(	NULL
5-GATTGTCCTCAT-TTCTCCAGATTATC	NULL
)	NULL
and	NULL
PM3	NULL
(	NULL
5-GCAATGATGGCACCA-CTGTACTCCAGC	NULL
)	NULL
.	NULL

PM2	NULL
and	NULL
PM3	NULL
should	NULL
allow	NULL
amplification	NULL
of	NULL
an	NULL
approximately	NULL
110-bp	NULL
fragment	NULL
spanning	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
.	NULL

;	NULL
,	NULL
dinucleotide	NULL
repeat	NULL
of	NULL
TALI	NULL
.	NULL

The	NULL
PM3	NULL
primer	NULL
was	NULL
5'-end	NULL
labeled	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
(	NULL
y-*P	NULL
)	NULL
ATP	NULL
.	NULL

The	NULL
PCR	NULL
reaction	NULL
consisted	NULL
of	NULL
1	NULL
ug	NULL
DNA	NULL
,	NULL
1	NULL
pmol/L	NULL
PM2	NULL
,	NULL
1	NULL
mol/L	NULL
PM3	NULL
,	NULL
and	NULL
2	NULL
U	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
PCR	NULL
buffer	NULL
(	NULL
50	NULL
mmol/L	NULL
KC1	NULL
,	NULL
10	NULL
mmol/L	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
9.01	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
2	NULL
mmol/L	NULL
MgCl1	NULL
;	NULL
,	NULL
and	NULL
0.2	NULL
mmol/L	NULL
of	NULL
each	NULL
deoxynucleotide	NULL
triphosphate	NULL
[	NULL
dNTP	NULL
]	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
reaction	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
50	NULL
uL	NULL
using	NULL
an	NULL
initial	NULL
melting	NULL
step	NULL
of	NULL
94Â°C	NULL
for	NULL
2	NULL
minutes	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
``	NULL
touchdown	NULL
``	NULL
'	NULL
protocol	NULL
consisting	NULL
of	NULL
94Â°C	NULL
for	NULL
1	NULL
minute	NULL
,	NULL
70Â°C	NULL
minus	NULL
1Â°C/cycle	NULL
for	NULL
1	NULL
minute	NULL
,	NULL
and	NULL
72Â°C	NULL
for	NULL
1	NULL
minute	NULL
for	NULL
a	NULL
total	NULL
of	NULL
10	NULL
cycles	NULL
,	NULL
followed	NULL
by	NULL
25	NULL
additional	NULL
cycles	NULL
of	NULL
94Â°C	NULL
for	NULL
1	NULL
minute	NULL
,	NULL
59Â°C	NULL
for	NULL
1	NULL
minute	NULL
,	NULL
and	NULL
72Â°C	NULL
for	NULL
1	NULL
minute	NULL
.	NULL

Five	NULL
microliters	NULL
of	NULL
the	NULL
amplified	NULL
product	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
5	NULL
uL	NULL
of	NULL
Stop	NULL
Solution	NULL
(	NULL
US	NULL
Biochemical	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
,	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
on	NULL
an	NULL
8	NULL
mol/L	NULL
urea	NULL
,	NULL
40	NULL
%	NULL
formamide	NULL
,	NULL
7	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

To	NULL
prepare	NULL
size	NULL
markers	NULL
for	NULL
analysis	NULL
of	NULL
amplified	NULL
fragments	NULL
from	NULL
leukemic	NULL
specimens	NULL
,	NULL
the	NULL
PCR	NULL
products	NULL
from	NULL
patients	NULL
no	NULL
.	NULL

13	NULL
,	NULL
26	NULL
,	NULL
and	NULL
30	NULL
were	NULL
ligated	NULL
into	NULL
the	NULL
pGEM4	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
;	NULL
individual	NULL
clones	NULL
with	NULL
12	NULL
copies	NULL
(	NULL
plasmid	NULL
A	NULL
)	NULL
,	NULL
13	NULL
copies	NULL
(	NULL
plasmid	NULL
B	NULL
)	NULL
,	NULL
and	NULL
14	NULL
copies	NULL
(	NULL
plasmid	NULL
C	NULL
)	NULL
of	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
dinucleotide	NULL
repeat	NULL
were	NULL
identified	NULL
by	NULL
nucleotide	NULL
sequence	NULL
analysis	NULL
.	NULL

Ten	NULL
nano-grams	NULL
of	NULL
each	NULL
plasmid	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
for	NULL
16	NULL
cycles	NULL
with	NULL
primers	NULL
PM2	NULL
and	NULL
PM3	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
fractionated	NULL
as	NULL
described	NULL
above	NULL
to	NULL
provide	NULL
size	NULL
markers	NULL
for	NULL
amplified	NULL
fragments	NULL
containing	NULL
12	NULL
,	NULL
13	NULL
,	NULL
or	NULL
14	NULL
copies	NULL
of	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
repeat	NULL
.	NULL

Reverse	NULL
transcriptase-PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

Fifteen	NULL
leukemic	NULL
specimens	NULL
were	NULL
identified	NULL
that	NULL
expressed	NULL
TAL1	NULL
transcripts	NULL
and	NULL
were	NULL
polymorphic	NULL
at	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
;	NULL
.	NULL

,	NULL
,	NULL
marker	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
RNA	NULL
from	NULL
each	NULL
specimen	NULL
was	NULL
treated	NULL
with	NULL
2	NULL
U	NULL
of	NULL
RNase-free	NULL
DNaseI	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
and	NULL
80	NULL
U	NULL
RNase	NULL
inhibitor	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
50	NULL
mmol/L	NULL
sodium	NULL
acetate	NULL
,	NULL
10	NULL
mmol/L	NULL
MgCl1	NULL
;	NULL
,	NULL
and	NULL
2	NULL
mmol/L	NULL
CaCl	NULL
;	NULL
(	NULL
final	NULL
vol-ume	NULL
,	NULL
40	NULL
gL	NULL
)	NULL
at	NULL
37Â°C	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
extracted	NULL
once	NULL
with	NULL
phenol	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ug	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
;	NULL
;	NULL
primer	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
KCI	NULL
to	NULL
100	NULL
mmol/L	NULL
,	NULL
and	NULL
an	NULL
additional	NULL
40	NULL
U	NULL
of	NULL
RNase	NULL
inhibitor	NULL
.	NULL

The	NULL
primer	NULL
was	NULL
annealed	NULL
to	NULL
the	NULL
RNA	NULL
by	NULL
incubation	NULL
at	NULL
65Â°C	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
50Â°C	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
40Â°C	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

After	NULL
ethanol	NULL
precipitation	NULL
,	NULL
the	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
20	NULL
uL	NULL
of	NULL
5	NULL
mmol/L	NULL
MgC	NULL
)	NULL
,	NULL
50	NULL
mmol/L	NULL
KCI	NULL
,	NULL
10	NULL
mmol/L	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
9.0	NULL
)	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.2	NULL
mmol/L	NULL
each	NULL
dNTP	NULL
,	NULL
40	NULL
U	NULL
of	NULL
RNase	NULL
inhibitor	NULL
,	NULL
and	NULL
8	NULL
U	NULL
of	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
(	NULL
AMV	NULL
)	NULL
RT	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
incubated	NULL
at	NULL
42Â°C	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
99Â°C	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
and	NULL
5Â°C	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

An	NULL
initial	NULL
PCR	NULL
amplification	NULL
using	NULL
5	NULL
ul	NULL
of	NULL
cDNA	NULL
was	NULL
performed	NULL
(	NULL
100	NULL
L	NULL
final	NULL
volume	NULL
)	NULL
with	NULL
0.5	NULL
pmol/L	NULL
oligonucleotide	NULL
PM2	NULL
,	NULL
0.5	NULL
umol/L	NULL
oligonucleotide	NULL
PMI	NULL
(	NULL
5'-GATTGCTTGAGCCCAGAGTT	NULL
)	NULL
,	NULL
and	NULL
2	NULL
U	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
in	NULL
PCR	NULL
buffer	NULL
.	NULL

Twenty	NULL
cycles	NULL
of	NULL
the	NULL
PCR	NULL
reaction	NULL
were	NULL
conducted	NULL
at	NULL
94Â°C	NULL
for	NULL
1	NULL
minute	NULL
,	NULL
59Â°C	NULL
for	NULL
1	NULL
minute	NULL
,	NULL
and	NULL
72Â°C	NULL
for	NULL
1	NULL
minute	NULL
.	NULL

PCR	NULL
amplifications	NULL
of	NULL
genomic	NULL
DNA	NULL
and	NULL
cDNA	NULL
from	NULL
each	NULL
patient	NULL
were	NULL
then	NULL
performed	NULL
in	NULL
parallel	NULL
using	NULL
an	NULL
unlabeled	NULL
PM2	NULL
oligonucleotide	NULL
and	NULL
a	NULL
PM3	NULL
oligonucleotide	NULL
with	NULL
the	NULL
fluorescent	NULL
dye	NULL
phosphora-midite	NULL
,	NULL
6-FAM	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
linked	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
genomic	NULL
DNA	NULL
and	NULL
1	NULL
uL	NULL
of	NULL
the	NULL
corresponding	NULL
preamplified	NULL
cDNA	NULL
(	NULL
preamplified	NULL
using	NULL
the	NULL
PM1	NULL
and	NULL
PM2	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

668	NULL
BASH	NULL
ET	NULL
AL	NULL
Table	NULL
1	NULL
.	NULL

Rearrangement	NULL
and	NULL
Expression	NULL
of	NULL
the	NULL
TAL1	NULL
Gene	NULL
in	NULL
Leukemic	NULL
Cells	NULL
of	NULL
T-ALL	NULL
Patients	NULL
Differential	NULL
(	NULL
%	NULL
Cells	NULL
}	NULL
(	NULL
TG	NULL
)	NULL
.	NULL

,	NULL
TAL	NULL
?	NULL

TAL1	NULL
{	NULL
TG	NULL
}	NULL
,	NULL
Allele	NULL
Patient	NULL
No	NULL
.	NULL

Source	NULL
%	NULL
Ly	NULL
%	NULL
Mo	NULL
%	NULL
o	NULL
My	NULL
%	NULL
Eo	NULL
Alleles	NULL
Rearrangement	NULL
Expression	NULL
Expressed	NULL
1	NULL
BM	NULL
94	NULL
6	NULL
-	NULL
-	NULL
12	NULL
,	NULL
13	NULL
tal1	NULL
``	NULL
+	NULL
13	NULL
only	NULL
2	NULL
BM	NULL
99	NULL
1	NULL
-	NULL
-	NULL
ND	NULL
-	NULL
~	NULL
ND	NULL
3	NULL
BM	NULL
100	NULL
-	NULL
-	NULL
-	NULL
ND	NULL
-	NULL
~-	NULL
ND	NULL
4	NULL
BM	NULL
100	NULL
-	NULL
-	NULL
-	NULL
ND	NULL
-	NULL
ND	NULL
5	NULL
BM	NULL
87	NULL
9	NULL
2	NULL
2	NULL
ND	NULL
-	NULL
--	NULL
ND	NULL
6	NULL
BM	NULL
96	NULL
2	NULL
1	NULL
1	NULL
ND	NULL
-	NULL
+	NULL
ND	NULL
7	NULL
PB	NULL
97	NULL
2	NULL
1	NULL
--	NULL
12	NULL
-	NULL
+	NULL
ND	NULL
8	NULL
BM	NULL
12	NULL
,	NULL
13	NULL
--	NULL
+	NULL
12	NULL
,	NULL
13	NULL
9	NULL
BM	NULL
95	NULL
3	NULL
2	NULL
-	NULL
ND	NULL
-	NULL
+	NULL
ND	NULL
10	NULL
BM	NULL
99	NULL
--	NULL
1	NULL
-	NULL
ND	NULL
-	NULL
-	NULL
ND	NULL
1	NULL
BM	NULL
92	NULL
8	NULL
-	NULL
-	NULL
ND	NULL
-	NULL
+	NULL
ND	NULL
12	NULL
BM	NULL
98	NULL
-	NULL
2	NULL
-	NULL
ND	NULL
tal1	NULL
``	NULL
``	NULL
+	NULL
ND	NULL
13	NULL
PB	NULL
97	NULL
1	NULL
-	NULL
2	NULL
12	NULL
--	NULL
+	NULL
ND	NULL
14	NULL
BM	NULL
12	NULL
-	NULL
-	NULL
ND	NULL
15	NULL
PB	NULL
94	NULL
3	NULL
3	NULL
-	NULL
ND	NULL
-	NULL
-	NULL
ND	NULL
16	NULL
BM	NULL
100	NULL
~-	NULL
-	NULL
-	NULL
ND	NULL
-	NULL
+	NULL
ND	NULL
17	NULL
BM	NULL
ND	NULL
t	NULL
(	NULL
1	NULL
;	NULL
11	NULL
;	NULL
10	NULL
}	NULL
+	NULL
ND	NULL
18	NULL
BM	NULL
100	NULL
--	NULL
-	NULL
-	NULL
12	NULL
-	NULL
-	NULL
ND	NULL
19	NULL
BM	NULL
100	NULL
--	NULL
-	NULL
-	NULL
12	NULL
,	NULL
13	NULL
tal1	NULL
``	NULL
+	NULL
13	NULL
only	NULL
20	NULL
BM	NULL
98	NULL
2	NULL
-	NULL
--	NULL
12	NULL
,	NULL
13	NULL
--	NULL
+	NULL
12	NULL
,	NULL
13	NULL
21	NULL
BM	NULL
99	NULL
1	NULL
-	NULL
-	NULL
12	NULL
,	NULL
13	NULL
~	NULL
-	NULL
ND	NULL
22	NULL
BM	NULL
98	NULL
1	NULL
1	NULL
--	NULL
12	NULL
,	NULL
13	NULL
--	NULL
-	NULL
ND	NULL
23	NULL
BM	NULL
100	NULL
-	NULL
-	NULL
-	NULL
12	NULL
,	NULL
13	NULL
tain	NULL
``	NULL
+	NULL
12	NULL
only	NULL
24	NULL
BM	NULL
74	NULL
22	NULL
4	NULL
--	NULL
12	NULL
,	NULL
13	NULL
~-	NULL
+	NULL
12	NULL
,	NULL
13	NULL
25	NULL
BM	NULL
97	NULL
3	NULL
-	NULL
-	NULL
12	NULL
,	NULL
13	NULL
~-	NULL
-	NULL
ND	NULL
26	NULL
PB	NULL
82	NULL
16	NULL
2	NULL
-	NULL
12	NULL
,	NULL
13	NULL
tall	NULL
``	NULL
+	NULL
12	NULL
only	NULL
27	NULL
PB	NULL
100	NULL
-	NULL
-	NULL
-	NULL
12	NULL
,	NULL
13	NULL
-	NULL
-	NULL
ND	NULL
28	NULL
BM	NULL
94	NULL
6	NULL
--	NULL
-	NULL
12	NULL
,	NULL
13	NULL
tall	NULL
``	NULL
+	NULL
13	NULL
only	NULL
29	NULL
BM	NULL
95	NULL
3	NULL
2	NULL
-	NULL
12	NULL
,	NULL
13	NULL
-	NULL
+	NULL
13	NULL
only	NULL
30	NULL
BM	NULL
12	NULL
,	NULL
14	NULL
tall	NULL
``	NULL
+	NULL
14	NULL
only	NULL
31	NULL
BM	NULL
99	NULL
-	NULL
-	NULL
1	NULL
12	NULL
,	NULL
13	NULL
-	NULL
-	NULL
NO	NULL
32	NULL
BM	NULL
12	NULL
,	NULL
13	NULL
-	NULL
+	NULL
12	NULL
only	NULL
33	NULL
PB	NULL
100	NULL
-	NULL
--	NULL
-	NULL
12	NULL
,	NULL
13	NULL
-	NULL
+	NULL
12	NULL
only	NULL
34	NULL
BM	NULL
95	NULL
1	NULL
4	NULL
-	NULL
12	NULL
,	NULL
13	NULL
tal	NULL
``	NULL
+	NULL
13	NULL
only	NULL
35	NULL
PB	NULL
100	NULL
-	NULL
-	NULL
-	NULL
12	NULL
,	NULL
13	NULL
-	NULL
-	NULL
ND	NULL
36	NULL
PF	NULL
99	NULL
-	NULL
1	NULL
-	NULL
12	NULL
,	NULL
13	NULL
-	NULL
12	NULL
,	NULL
13	NULL
37	NULL
BM	NULL
97	NULL
1	NULL
2	NULL
-	NULL
12	NULL
,	NULL
13	NULL
tal1	NULL
``	NULL
+	NULL
13	NULL
only	NULL
Leukemic	NULL
specimens	NULL
were	NULL
obtained	NULL
at	NULL
diagnosis	NULL
from	NULL
BM	NULL
,	NULL
PB	NULL
,	NULL
or	NULL
PF	NULL
.	NULL

Patients	NULL
no	NULL
.	NULL

1	NULL
through	NULL
18	NULL
were	NULL
accrued	NULL
prospectively	NULL
by	NULL
the	NULL
POG	NULL
between	NULL
August	NULL
1992	NULL
and	NULL
December	NULL
1992	NULL
.	NULL

Specimens	NULL
from	NULL
patients	NULL
no	NULL
.	NULL

19	NULL
through	NULL
37	NULL
were	NULL
obtained	NULL
retrospectively	NULL
after	NULL
screening	NULL
the	NULL
POG	NULL
Cell	NULL
Bank	NULL
for	NULL
samples	NULL
that	NULL
are	NULL
heterozygous	NULL
for	NULL
the	NULL
{	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
.	NULL

,	NULL
,	NULL
marker	NULL
of	NULL
TAL	NULL
1	NULL
.	NULL

Differential	NULL
nucleated	NULL
cell	NULL
counts	NULL
were	NULL
performed	NULL
on	NULL
each	NULL
sample	NULL
;	NULL
all	NULL
samples	NULL
were	NULL
devoid	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL

The	NULL
typing	NULL
of	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
1	NULL
,	NULL
alleles	NULL
in	NULL
the	NULL
genomic	NULL
DNA	NULL
of	NULL
each	NULL
specimen	NULL
was	NULL
conducted	NULL
by	NULL
PCR	NULL
analysis	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
and	NULL
nature	NULL
of	NULL
detectable	NULL
TAL	NULL
1	NULL
gene	NULL
rearrangements	NULL
were	NULL
determined	NULL
by	NULL
Southern	NULL
hybridization	NULL
,	NULL
PCR	NULL
amplification	NULL
,	NULL
and	NULL
cytogenetic	NULL
analysis	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
TAL	NULL
1	NULL
transcripts	NULL
was	NULL
established	NULL
by	NULL
ribonuclease	NULL
protection	NULL
analysis	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
and	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
allele	NULL
(	NULL
s	NULL
)	NULL
expressed	NULL
was	NULL
identified	NULL
by	NULL
PCR	NULL
analysis	NULL
(	NULL
Figs	NULL
5-7	NULL
)	NULL
.	NULL

Abbreviations	NULL
:	NULL
Ly	NULL
,	NULL
lymphoblasts	NULL
and	NULL
lymphocytes	NULL
;	NULL
Mo	NULL
,	NULL
monocytes	NULL
;	NULL
My	NULL
,	NULL
myeloid	NULL
series	NULL
;	NULL
Eo	NULL
,	NULL
eosinophils	NULL
;	NULL
PF	NULL
,	NULL
pleural	NULL
fluid	NULL
.	NULL

primers	NULL
as	NULL
described	NULL
above	NULL
)	NULL
were	NULL
added	NULL
separately	NULL
to	NULL
parallel	NULL
100	NULL
uL	NULL
reactions	NULL
containing	NULL
0.5	NULL
gmol/L	NULL
of	NULL
oligonucleotides	NULL
PM2	NULL
and	NULL
PM3	NULL
,	NULL
50	NULL
pmol/L	NULL
6-FAM-labeled	NULL
oligonucleotide	NULL
PM3	NULL
,	NULL
and	NULL
2	NULL
U	NULL
of	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
in	NULL
PCR	NULL
buffer	NULL
.	NULL

Touchdown	NULL
PCR	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
using	NULL
an	NULL
initial	NULL
melting	NULL
step	NULL
,	NULL
10	NULL
cycles	NULL
of	NULL
touchdown	NULL
PCR	NULL
and	NULL
21	NULL
,	NULL
24	NULL
,	NULL
and	NULL
28	NULL
additional	NULL
cycles	NULL
of	NULL
standard	NULL
PCR	NULL
.	NULL

Two	NULL
microliters	NULL
of	NULL
a	NULL
1:10	NULL
dilution	NULL
of	NULL
each	NULL
amplification	NULL
reaction	NULL
were	NULL
mixed	NULL
with	NULL
0.5	NULL
gL	NULL
of	NULL
8	NULL
nmol/L	NULL
GENESCAN	NULL
2500	NULL
sizing	NULL
standards	NULL
(	NULL
Applied	NULL
Biosystems	NULL
)	NULL
and	NULL
4	NULL
gL	NULL
deionized	NULL
formamide	NULL
.	NULL

The	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
90Â°C	NULL
for	NULL
2	NULL
minutes	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
then	NULL
loaded	NULL
onto	NULL
a	NULL
7	NULL
mol/L	NULL
urea	NULL
,	NULL
7	NULL
%	NULL
Long	NULL
Ranger	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
AT	NULL
Biochem	NULL
)	NULL
in	NULL
an	NULL
automated	NULL
373A	NULL
DNA	NULL
Sequencer	NULL
(	NULL
Applied	NULL
Biosystems	NULL
)	NULL
and	NULL
run	NULL
12	NULL
cm	NULL
'well	NULL
to	NULL
read	NULL
``	NULL
using	NULL
the	NULL
GENESCAN	NULL
672	NULL
Software	NULL
(	NULL
version	NULL
1.2	NULL
;	NULL
Applied	NULL
Biosystems	NULL
)	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
determined	NULL
by	NULL
comparison	NULL
with	NULL
the	NULL
internal	NULL
GENESCAN	NULL
2500	NULL
sizing	NULL
standards	NULL
using	NULL
the	NULL
Local	NULL
Southern	NULL
Method	NULL
.	NULL
``	NULL

After	NULL
sizing	NULL
,	NULL
the	NULL
fluorescent	NULL
patterns	NULL
for	NULL
parallel	NULL
DNA	NULL
and	NULL
cDNA	NULL
reactions	NULL
were	NULL
overlaid	NULL
for	NULL
comparison	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
The	NULL
presence	NULL
of	NULL
TAL1	NULL
transcripts	NULL
in	NULL
the	NULL
malignant	NULL
cells	NULL
of	NULL
T-ALL	NULL
patients	NULL
.	NULL

-	NULL
TAL	NULL
]	NULL
gene	NULL
products	NULL
are	NULL
present	NULL
in	NULL
some	NULL
T-ALL	NULL
cell	NULL
lines	NULL
that	NULL
do	NULL
not	NULL
have	NULL
obvious	NULL
alterations	NULL
of	NULL
the	NULL
TAL1	NULL
gene	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
,	NULL
and	NULL
to	NULL
what	NULL
extent	NULL
,	NULL
TAL	NULL
]	NULL
transcription	NULL
occurs	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TAL	NULL
]	NULL
gene	NULL
rearrangement	NULL
in	NULL
primary	NULL
T-ALL	NULL
cells	NULL
.	NULL

Samples	NULL
of	NULL
BM	NULL
,	NULL
PB	NULL
,	NULL
or	NULL
PF	NULL
were	NULL
obtained	NULL
from	NULL
37	NULL
T-ALL	NULL
patients	NULL
at	NULL
diagnosis	NULL
.	NULL

After	NULL
fractionation	NULL
on	NULL
a	NULL
Ficoll-Hypaque	NULL
gradi-ent	NULL
,	NULL
genomic	NULL
DNA	NULL
and	NULL
total	NULL
cellular	NULL
RNA	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
enriched	NULL
population	NULL
of	NULL
lymphoblasts	NULL
.	NULL

The	NULL
genomic	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ACTIVATION	NULL
OF	NULL
THE	NULL
TAL	NULL
?	NULL

GENE	NULL
B2EE-2.0	NULL
1A	NULL
18	NULL
2B	NULL
2A	NULL
3	NULL
TAL1	NULL
exons	NULL
669	NULL
Fig	NULL
1	NULL
.	NULL

The	NULL
normal	NULL
structure	NULL
of	NULL
the	NULL
TAL1	NULL
locus	NULL
on	NULL
chromosome	NULL
band	NULL
1p34	NULL
.	NULL

The	NULL
endpoints	NULL
of	NULL
the	NULL
tal	NULL
``	NULL
``	NULL
and	NULL
tal	NULL
``	NULL
deletions	NULL
are	NULL
denoted	NULL
with	NULL
arrows	NULL
;	NULL
the	NULL
upstream	NULL
endpoint	NULL
is	NULL
identical	NULL
,	NULL
and	NULL
arrows	NULL
denoting	NULL
the	NULL
downstream	NULL
endpoints	NULL
are	NULL
marked	NULL
d1	NULL
(	NULL
tal	NULL
``	NULL
``	NULL
)	NULL
and	NULL
d2	NULL
(	NULL
tal	NULL
)	NULL
.	NULL

Intervening	NULL
DNA	NULL
sequences	NULL
(	NULL
90	NULL
to	NULL
100	NULL
kb	NULL
)	NULL
are	NULL
deleted	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
tal	NULL
?	NULL
``	NULL

rearrangements	NULL
.	NULL

The	NULL
major	NULL
breakpoint	NULL
region	NULL
for	NULL
the	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p34	NULL
;	NULL
q11	NULL
)	NULL
translocation	NULL
is	NULL
indicated	NULL
.	NULL

Restriction	NULL
sites	NULL
:	NULL
H	NULL
,	NULL
HindIII	NULL
;	NULL
E	NULL
,	NULL
EcoRI	NULL
.	NULL

The	NULL
probes	NULL
AA-0.6	NULL
and	NULL
B2EE-2.0	NULL
were	NULL
used	NULL
for	NULL
Southern	NULL
analysis	NULL
to	NULL
detect	NULL
TAL1	NULL
gene	NULL
rearrangements	NULL
.	NULL

The	NULL
TAL1	NULL
exons	NULL
are	NULL
indicated	NULL
,	NULL
and	NULL
the	NULL
coding	NULL
sequences	NULL
within	NULL
exons	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
are	NULL
shaded	NULL
in	NULL
black	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
>	NULL
.	NULL

,	NULL
,	NULL
polymorphism	NULL
within	NULL
exon	NULL
6	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
TAL1-specific	NULL
probe	NULL
for	NULL
the	NULL
ribonuclease	NULL
protection	NULL
analysis	NULL
includes	NULL
141	NULL
antisense	NULL
cDNA	NULL
residues	NULL
that	NULL
span	NULL
the	NULL
exon	NULL
5-exon	NULL
6	NULL
junction	NULL
.	NULL

These	NULL
residues	NULL
are	NULL
complimentary	NULL
to	NULL
the	NULL
3'-terminal	NULL
47	NULL
nucleotides	NULL
of	NULL
exon	NULL
5	NULL
and	NULL
the	NULL
5'-terminal	NULL
94	NULL
nucleotides	NULL
of	NULL
exon	NULL
6	NULL
.	NULL

DNA	NULL
was	NULL
examined	NULL
for	NULL
tumor-specific	NULL
TAL	NULL
]	NULL
gene	NULL
rearrangement	NULL
by	NULL
Southern	NULL
analysis	NULL
and	NULL
PCR	NULL
amplification	NULL
.	NULL

As	NULL
described	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
10	NULL
of	NULL
the	NULL
37	NULL
patients	NULL
had	NULL
TALI	NULL
gene	NULL
rearrangements	NULL
,	NULL
8	NULL
of	NULL
which	NULL
arose	NULL
by	NULL
tal	NULL
``	NULL
'	NULL
recombination	NULL
.	NULL

During	NULL
normal	NULL
hematopoiesis	NULL
,	NULL
transcription	NULL
of	NULL
the	NULL
TALI	NULL
gene	NULL
occurs	NULL
in	NULL
progenitors	NULL
of	NULL
the	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
mastocytic	NULL
lineages	NULL
.	NULL
``	NULL

''	NULL
The	NULL
presence	NULL
of	NULL
these	NULL
normal	NULL
cells	NULL
in	NULL
BM	NULL
aspirates	NULL
from	NULL
T-ALL	NULL
patients	NULL
could	NULL
potentially	NULL
confound	NULL
the	NULL
analysis	NULL
of	NULL
tumor-specific	NULL
TAL	NULL
]	NULL
expression	NULL
,	NULL
especially	NULL
if	NULL
RNA	NULL
transcripts	NULL
were	NULL
measured	NULL
by	NULL
a	NULL
PCR-based	NULL
amplification	NULL
method	NULL
.	NULL

Instead	NULL
,	NULL
however	NULL
,	NULL
total	NULL
cellular	NULL
RNAs	NULL
from	NULL
the	NULL
leukemic	NULL
cells	NULL
from	NULL
each	NULL
patient	NULL
were	NULL
evaluated	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
TAL	NULL
]	NULL
transcripts	NULL
using	NULL
a	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
.	NULL

Moreover	NULL
,	NULL
differential	NULL
counts	NULL
of	NULL
the	NULL
enriched	NULL
mononuclear	NULL
fractions	NULL
showed	NULL
that	NULL
each	NULL
sample	NULL
contained	NULL
fewer	NULL
than	NULL
1	NULL
%	NULL
erythroid	NULL
and	NULL
5	NULL
%	NULL
myeloid	NULL
cells	NULL
.	NULL

Although	NULL
some	NULL
samples	NULL
had	NULL
higher	NULL
proportions	NULL
of	NULL
mature	NULL
monocytes	NULL
,	NULL
previous	NULL
studies	NULL
have	NULL
established	NULL
that	NULL
BM	NULL
and	NULL
PB	NULL
monocytes	NULL
do	NULL
not	NULL
express	NULL
TAL	NULL
]	NULL
gene	NULL
products	NULL
.	NULL
``	NULL

''	NULL
``	NULL
'	NULL
As	NULL
illustrated	NULL
in	NULL
Fig	NULL
2	NULL
,	NULL
TAL	NULL
]	NULL
transcripts	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
leukemic	NULL
specimens	NULL
from	NULL
several	NULL
patients	NULL
with	NULL
T-ALL	NULL
(	NULL
eg	NULL
,	NULL
patients	NULL
no	NULL
.	NULL

2	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
BM-derived	NULL
specimens	NULL
from	NULL
3	NULL
patients	NULL
with	NULL
early	NULL
B-lineage	NULL
ALL	NULL
were	NULL
also	NULL
evaluated	NULL
and	NULL
shown	NULL
to	NULL
be	NULL
devoid	NULL
of	NULL
TAL	NULL
]	NULL
transcripts	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
Ficoll-Hypaque	NULL
centrifugation	NULL
adequately	NULL
removes	NULL
normal	NULL
TAL/-expressing	NULL
progenitors	NULL
from	NULL
the	NULL
leukemic	NULL
fraction	NULL
,	NULL
at	NULL
least	NULL
to	NULL
a	NULL
degree	NULL
sufficient	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
RNA	NULL
transcripts	NULL
using	NULL
a	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
each	NULL
of	NULL
the	NULL
10	NULL
T-ALL	NULL
patients	NULL
with	NULL
tumor-specific	NULL
TALI	NULL
gene	NULL
rearrangements	NULL
harbored	NULL
TAL	NULL
]	NULL
transcripts	NULL
in	NULL
their	NULL
leukemic	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
TALI	NULL
transcripts	NULL
were	NULL
also	NULL
abundant	NULL
in	NULL
leukemic	NULL
cells	NULL
from	NULL
a	NULL
significant	NULL
proportion	NULL
of	NULL
patients	NULL
without	NULL
apparent	NULL
TAL	NULL
]	NULL
gene	NULL
alterations	NULL
(	NULL
eg	NULL
,	NULL
patients	NULL
no	NULL
.	NULL

6	NULL
,	NULL
7	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
;	NULL
see	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

In	NULL
total	NULL
,	NULL
23	NULL
of	NULL
the	NULL
37	NULL
patients	NULL
showed	NULL
TALI	NULL
expression	NULL
,	NULL
including	NULL
13	NULL
that	NULL
did	NULL
not	NULL
harbor	NULL
TALL	NULL
gene	NULL
rearrangements	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

A	NULL
polymorphic	NULL
marker	NULL
in	NULL
the	NULL
transcribed	NULL
sequences	NULL
of	NULL
TALLI	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
TAL	NULL
]	NULL
in	NULL
T-lineage	NULL
cells	NULL
may	NULL
result	NULL
from	NULL
tumor-specific	NULL
DNA	NULL
alterations	NULL
that	NULL
affect	NULL
one	NULL
of	NULL
the	NULL
two	NULL
TAL	NULL
]	NULL
alleles	NULL
.	NULL

These	NULL
alterations	NULL
in	NULL
cis	NULL
may	NULL
arise	NULL
from	NULL
gross	NULL
structural	NULL
rearrangements	NULL
such	NULL
as	NULL
those	NULL
engendered	NULL
by	NULL
chromosome	NULL
translocation	NULL
or	NULL
tal	NULL
``	NULL
recombination	NULL
or	NULL
from	NULL
more	NULL
subtle	NULL
changes	NULL
such	NULL
as	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
regulatory	NULL
sequences	NULL
of	NULL
TALI	NULL
.	NULL

In	NULL
either	NULL
case	NULL
,	NULL
cis	NULL
activation	NULL
should	NULL
induce	NULL
monoallelic	NULL
transcription	NULL
of	NULL
the	NULL
TAL	NULL
]	NULL
gene	NULL
.	NULL

Alternatively	NULL
,	NULL
ectopic	NULL
TAL	NULL
]	NULL
expression	NULL
may	NULL
also	NULL
occur	NULL
as	NULL
a	NULL
result	NULL
of	NULL
tumor-specific	NULL
changes	NULL
in	NULL
trans-acting	NULL
factors	NULL
that	NULL
control	NULL
TAL	NULL
]	NULL
expression	NULL
.	NULL

Although	NULL
evidence	NULL
for	NULL
trans-acti-vation	NULL
of	NULL
the	NULL
TALI	NULL
gene	NULL
in	NULL
T-ALL	NULL
has	NULL
not	NULL
yet	NULL
emerged	NULL
,	NULL
this	NULL
phenomenon	NULL
is	NULL
likely	NULL
to	NULL
induce	NULL
biallelic	NULL
TAL	NULL
]	NULL
transcription	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
monoallelic	NULL
and	NULL
biallelic	NULL
TALZ	NULL
expression	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
identify	NULL
a	NULL
polymorphism	NULL
within	NULL
the	NULL
transcribed	NULL
sequences	NULL
of	NULL
TAL	NULL
]	NULL
.	NULL

Significantly	NULL
,	NULL
the	NULL
3'-untrans-lated	NULL
region	NULL
of	NULL
exon	NULL
6	NULL
contains	NULL
a	NULL
simple	NULL
repeat	NULL
sequence	NULL
that	NULL
includes	NULL
12	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
TG	NULL
dinucleotide	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

(	NULL
TG	NULL
)	NULL
,	NULL
dinucleotide	NULL
repeats	NULL
,	NULL
especially	NULL
those	NULL
of	NULL
higher	NULL
multiplicity	NULL
(	NULL
ie	NULL
,	NULL
where	NULL
n	NULL
>	NULL
20	NULL
)	NULL
,	NULL
are	NULL
usually	NULL
polymorphic	NULL
in	NULL
mammals	NULL
.	NULL
``	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
repeat	NULL
in	NULL
exon	NULL
6	NULL
of	NULL
TAL1	NULL
is	NULL
polymorphic	NULL
,	NULL
DNA	NULL
fragments	NULL
encompassing	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
sequence	NULL
were	NULL
generated	NULL
from	NULL
the	NULL
leukemic	NULL
DNAs	NULL
of	NULL
219	NULL
T-ALL	NULL
patients	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
a	NULL
common	NULL
pair	NULL
of	NULL
oligonucleotide	NULL
primers	NULL
(	NULL
PM2	NULL
and	NULL
PM3	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
then	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
on	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

PCR	NULL
amplification	NULL
of	NULL
leukemic	NULL
DNAs	NULL
from	NULL
most	NULL
patients	NULL
produced	NULL
a	NULL
single	NULL
DNA	NULL
fragment	NULL
;	NULL
molecular	NULL
cloning	NULL
and	NULL
nucleotide	NULL
sequence	NULL
analysis	NULL
showed	NULL
that	NULL
this	NULL
fragment	NULL
contains	NULL
12	NULL
copies	NULL
of	NULL
the	NULL
TG	NULL
dinucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
fragments	NULL
of	NULL
distinct	NULL
sizes	NULL
were	NULL
also	NULL
observed	NULL
among	NULL
the	NULL
PCR	NULL
products	NULL
from	NULL
some	NULL
patients	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

670	NULL
tal1tÂ©	NULL
allele	NULL
_+	NULL
-	NULL
_	NULL
-	NULL
_-	NULL
-	NULL
-_-TAL1	NULL
mRNA	NULL
|	NULL
4+	NULL
-o-	NULL
o-	NULL
-	NULL
+0	NULL
+	NULL
TAL1	NULL
4+	NULL
â	NULL
GADP	NULL
-	NULL
>	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
sequence	NULL
analysis	NULL
showed	NULL
that	NULL
these	NULL
additional	NULL
fragments	NULL
possess	NULL
either	NULL
13	NULL
or	NULL
14	NULL
copies	NULL
of	NULL
the	NULL
dinucleotide	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
,	NULL
,	NULL
,	NULL
sequence	NULL
of	NULL
TAL	NULL
]	NULL
is	NULL
polymorphic	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
dinucleotide	NULL
repeat	NULL
polymorphisms	NULL
is	NULL
TAL1	NULL
-m	NULL
Â»	NULL
GADP	NULL
-m	NULL
1|B1	NULL
B2	NULL
B3	NULL
B-lineage	NULL
ALL	NULL
Fig	NULL
3	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
TAL1	NULL
gene	NULL
transcripts	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
with	NULL
B-lineage	NULL
ALL	NULL
.	NULL

Mononuclear	NULL
fractions	NULL
of	NULL
leukemic	NULL
lymphoblasts	NULL
were	NULL
obtained	NULL
by	NULL
Ficoll-Hypaque	NULL
centrifugation	NULL
of	NULL
BM	NULL
specimens	NULL
from	NULL
3	NULL
patients	NULL
with	NULL
early	NULL
B-lineage	NULL
ALL	NULL
(	NULL
patients	NULL
no	NULL
.	NULL

B1	NULL
,	NULL
B2	NULL
,	NULL
and	NULL
B3	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNAs	NULL
were	NULL
then	NULL
extracted	NULL
from	NULL
the	NULL
enriched	NULL
lymphoblasts	NULL
and	NULL
evaluated	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
TAL1	NULL
gene	NULL
transcripts	NULL
by	NULL
ribonuclease	NULL
protection	NULL
analysis	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

TAL1	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
from	NULL
T-ALL	NULL
patient	NULL
no	NULL
.	NULL

1	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
but	NULL
not	NULL
from	NULL
B-lineage	NULL
ALL	NULL
patients	NULL
no	NULL
.	NULL

B1	NULL
,	NULL
B2	NULL
,	NULL
or	NULL
B3	NULL
.	NULL

BASH	NULL
ET	NULL
AL	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
TAL1	NULL
gene	NULL
transcripts	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
T-ALL	NULL
patients	NULL
.	NULL

``	NULL
P-labeled	NULL
antisense	NULL
RNA	NULL
probes	NULL
were	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
a	NULL
TAL1	NULL
plasmid	NULL
(	NULL
tal1CB/pGEM4	NULL
)	NULL
and	NULL
a	NULL
GADP	NULL
plasmid	NULL
(	NULL
pGADP4/pGEM7	NULL
)	NULL
.	NULL

A	NULL
10-pq	NULL
aliquot	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
each	NULL
patient	NULL
was	NULL
hybridized	NULL
simultaneously	NULL
with	NULL
the	NULL
TAL1	NULL
and	NULL
GADP	NULL
probes	NULL
.	NULL

After	NULL
RNase	NULL
treatment	NULL
and	NULL
gel	NULL
electrophoresis	NULL
,	NULL
protected	NULL
fragments	NULL
of	NULL
the	NULL
TAL1	NULL
(	NULL
141	NULL
nucleotides	NULL
)	NULL
and	NULL
GADP	NULL
(	NULL
103	NULL
nucleotides	NULL
)	NULL
probes	NULL
were	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
number	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
lane	NULL
corresponds	NULL
to	NULL
the	NULL
patient	NULL
numbers	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Patient	NULL
no	NULL
.	NULL

1	NULL
harbored	NULL
a	NULL
TAL1	NULL
gene	NULL
rearrangement	NULL
(	NULL
tal	NULL
``	NULL
``	NULL
)	NULL
.	NULL

TAL1	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
no	NULL
.	NULL

1	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9.	NULL
commonly	NULL
complicated	NULL
by	NULL
the	NULL
present	NULL
of	NULL
``	NULL
shadow	NULL
bands	NULL
'	NULL
``	NULL
that	NULL
arise	NULL
by	NULL
slipped-strand	NULL
mispairing	NULL
during	NULL
PCR	NULL
amplifi-cation	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
to	NULL
score	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
;	NULL
,	NULL
allele	NULL
reliably	NULL
in	NULL
a	NULL
large	NULL
panel	NULL
of	NULL
T-ALL	NULL
patients	NULL
,	NULL
PCR	NULL
fragments	NULL
containing	NULL
12	NULL
,	NULL
13	NULL
,	NULL
or	NULL
14	NULL
copies	NULL
of	NULL
the	NULL
TG	NULL
dinucleotide	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pGEM4	NULL
plasmid	NULL
vector	NULL
.	NULL

The	NULL
resultant	NULL
plasmids	NULL
were	NULL
then	NULL
used	NULL
as	NULL
PCR	NULL
templates	NULL
to	NULL
generate	NULL
amplified	NULL
fragments	NULL
of	NULL
known	NULL
size	NULL
to	NULL
serve	NULL
as	NULL
electrophoretic	NULL
mobility	NULL
standards	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
,	NULL
PCR	NULL
amplification	NULL
of	NULL
genomic	NULL
DNA	NULL
from	NULL
patient	NULL
no	NULL
.	NULL

13	NULL
generated	NULL
a	NULL
major	NULL
PCR	NULL
product	NULL
that	NULL
comigrated	NULL
with	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
,	NULL
standard	NULL
derived	NULL
from	NULL
plasmid	NULL
A	NULL
.	NULL

Although	NULL
a	NULL
minor	NULL
shadow	NULL
band	NULL
containing	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
is	NULL
also	NULL
apparent	NULL
,	NULL
this	NULL
analysis	NULL
indicates	NULL
that	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patient	NULL
no	NULL
.	NULL

13	NULL
are	NULL
homozygous	NULL
(	NULL
or	NULL
hemizygous	NULL
)	NULL
for	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
;	NULL
allele	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
patients	NULL
no	NULL
.	NULL

26	NULL
and	NULL
30	NULL
were	NULL
heterozygous	NULL
for	NULL
this	NULL
marker	NULL
;	NULL
patient	NULL
no	NULL
.	NULL

26	NULL
possessed	NULL
both	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
,	NULL
and	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
alleles	NULL
,	NULL
whereas	NULL
patient	NULL
no	NULL
.	NULL

30	NULL
had	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
,	NULL
and	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
,	NULL
alleles	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

The	NULL
same	NULL
analysis	NULL
was	NULL
applied	NULL
to	NULL
leukemic	NULL
DNAs	NULL
from	NULL
a	NULL
total	NULL
of	NULL
219	NULL
T-ALL	NULL
patients	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
,	NULL
40	NULL
of	NULL
these	NULL
patients	NULL
(	NULL
18.3	NULL
%	NULL
)	NULL
displayed	NULL
heterozygosity	NULL
for	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
.	NULL

,	NULL
marker	NULL
.	NULL

Similarly	NULL
,	NULL
84	NULL
nonleukemic	NULL
DNAs	NULL
were	NULL
evaluated	NULL
,	NULL
and	NULL
12	NULL
of	NULL
these	NULL
(	NULL
14.3	NULL
%	NULL
)	NULL
were	NULL
found	NULL
to	NULL
be	NULL
heterozygous	NULL
for	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
;	NULL
4	NULL
marker	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Biallelic	NULL
expression	NULL
of	NULL
TAL1	NULL
occurs	NULL
in	NULL
normal	NULL
tissues	NULL
.	NULL

-	NULL
If	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
1	NULL
,	NULL
marker	NULL
is	NULL
to	NULL
be	NULL
informative	NULL
of	NULL
allele-specific	NULL
TALL	NULL
expression	NULL
,	NULL
then	NULL
nonleukemic	NULL
cells	NULL
that	NULL
normally	NULL
express	NULL
TALI	NULL
must	NULL
show	NULL
a	NULL
biallelic	NULL
pattern	NULL
of	NULL
transcription	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
normal	NULL
individual	NULL
polymorphic	NULL
for	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
,	NULL
marker	NULL
of	NULL
TAL	NULL
]	NULL
was	NULL
identified	NULL
,	NULL
and	NULL
a	NULL
BM	NULL
aspirate	NULL
was	NULL
obtained	NULL
.	NULL

RNA	NULL
was	NULL
then	NULL
extracted	NULL
from	NULL
the	NULL
BM	NULL
cells	NULL
,	NULL
annealed	NULL
with	NULL
an	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
;	NULL
s	NULL
primer	NULL
,	NULL
and	NULL
converted	NULL
to	NULL
complementary	NULL
DNA	NULL
(	NULL
cDNA	NULL
)	NULL
with	NULL
RT	NULL
.	NULL

The	NULL
cDNA	NULL
product	NULL
and	NULL
the	NULL
corresponding	NULL
genomic	NULL
DNA	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
were	NULL
then	NULL
PCR-amplified	NULL
in	NULL
parallel	NULL
with	NULL
oligonucleotide	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ACTIVATION	NULL
OF	NULL
THE	NULL
TAL1	NULL
GENE	NULL
cls	NULL
:	NULL
sie	NULL
:	NULL
_	NULL
_-	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
Â«	NULL
e	NULL
*~	NULL
_	NULL
the	NULL
He	NULL
as	NULL
__	NULL
Â¢	NULL
.	NULL

-*	NULL
T	NULL
w	NULL
a	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
A	NULL
B	NULL
_C	NULL
30	NULL
26	NULL
13	NULL
plasmid	NULL
patient	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Polymorphic	NULL
variation	NULL
of	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
.1	NULL
,	NULL
marker	NULL
in	NULL
the	NULL
leukemic	NULL
DNAs	NULL
of	NULL
T-ALL	NULL
patients	NULL
.	NULL

Genomic	NULL
DNAs	NULL
from	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
T-ALL	NULL
patients	NULL
(	NULL
no	NULL
.	NULL

30	NULL
,	NULL
26	NULL
,	NULL
and	NULL
13	NULL
;	NULL
see	NULL
Table	NULL
1	NULL
)	NULL
were	NULL
PCR-amplified	NULL
along	NULL
with	NULL
the	NULL
control	NULL
plasmids	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
The	NULL
amplification	NULL
reactions	NULL
were	NULL
primed	NULL
with	NULL
oligonucleotides	NULL
(	NULL
PM2	NULL
and	NULL
**P-labeled	NULL
PM3	NULL
)	NULL
that	NULL
flank	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
.	NULL

,	NULL
,	NULL
marker	NULL
of	NULL
TAL1	NULL
,	NULL
and	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
fractionated	NULL
by	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
amplified	NULL
from	NULL
plasmids	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
provide	NULL
size	NULL
markers	NULL
for	NULL
DNA	NULL
fragments	NULL
containing	NULL
12	NULL
,	NULL
13	NULL
,	NULL
or	NULL
14	NULL
copies	NULL
of	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
dinucleotide	NULL
repeat	NULL
,	NULL
respectively	NULL
.	NULL

primers	NULL
that	NULL
flank	NULL
the	NULL
polymorphic	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
,	NULL
,	NULL
marker	NULL
(	NULL
PM2	NULL
and	NULL
fluorescenated	NULL
PM3	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
products	NULL
were	NULL
fractionated	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
373A	NULL
DNA	NULL
Sequencer	NULL
along	NULL
with	NULL
GENESCAN	NULL
2500	NULL
sizing	NULL
standards	NULL
.	NULL

The	NULL
fluorescent	NULL
patterns	NULL
of	NULL
PCR	NULL
products	NULL
amplified	NULL
in	NULL
parallel	NULL
from	NULL
the	NULL
cDNA	NULL
and	NULL
genomic	NULL
DNA	NULL
were	NULL
then	NULL
aligned	NULL
according	NULL
to	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
sizing	NULL
standards	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
,	NULL
the	NULL
genomic	NULL
DNA	NULL
and	NULL
cDNA	NULL
both	NULL
show	NULL
a	NULL
biallelic	NULL
pattern	NULL
of	NULL
amplification	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
transcription	NULL
occurs	NULL
from	NULL
both	NULL
alleles	NULL
of	NULL
TAL	NULL
]	NULL
in	NULL
normal	NULL
BM	NULL
cells	NULL
and	NULL
,	NULL
thereby	NULL
,	NULL
justifies	NULL
the	NULL
use	NULL
of	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
;	NULL
,	NULL
,	NULL
repeat	NULL
as	NULL
a	NULL
marker	NULL
of	NULL
allele-specific	NULL
TALI	NULL
transcription	NULL
in	NULL
T-ALL	NULL
cells	NULL
.	NULL

Monoallelic	NULL
expression	NULL
of	NULL
the	NULL
rearranged	NULL
TAL1	NULL
genes	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
malignant	NULL
activation	NULL
of	NULL
TAL	NULL
]	NULL
results	NULL
in	NULL
monoallelic	NULL
or	NULL
biallelic	NULL
expression	NULL
,	NULL
TAL	NULL
1	NULL
transcripts	NULL
were	NULL
evaluated	NULL
from	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
that	NULL
were	NULL
heterozygous	NULL
for	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
,	NULL
,	NULL
marker	NULL
.	NULL

Leukemic	NULL
cells	NULL
were	NULL
available	NULL
in	NULL
quantities	NULL
sufficient	NULL
for	NULL
RNA	NULL
analysis	NULL
from	NULL
21	NULL
heterozygous	NULL
patients	NULL
.	NULL

The	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
Table	NULL
2	NULL
.	NULL

Allelic	NULL
Frequencies	NULL
of	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
Marker	NULL
of	NULL
TAL1	NULL
Patient	NULL
Population	NULL
Genotype	NULL
T-ALL	NULL
Nonleukemic	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
;	NULL
only	NULL
179	NULL
72	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
,	NULL
(	NULL
TGhs	NULL
38	NULL
10	NULL
(	NULL
TG	NULL
)	NULL
Â»	NULL
,	NULL
(	NULL
TGha	NULL
2	NULL
1	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
3	NULL
,	NULL
(	NULL
TG	NULL
)	NULL
Â«	NULL
0	NULL
1	NULL
Total	NULL
219	NULL
84	NULL
Genomic	NULL
DNA	NULL
from	NULL
219	NULL
T-ALL	NULL
and	NULL
84	NULL
nonleukemic	NULL
samples	NULL
was	NULL
typed	NULL
for	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
.	NULL

;	NULL
,	NULL
alleles	NULL
of	NULL
TAL1	NULL
by	NULL
PCR	NULL
analysis	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
219	NULL
leukemic	NULL
specimens	NULL
,	NULL
40	NULL
(	NULL
18.3	NULL
%	NULL
)	NULL
showed	NULL
heterozygosity	NULL
of	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
marker	NULL
of	NULL
TAL1	NULL
.	NULL

Similarly	NULL
,	NULL
12	NULL
(	NULL
14.3	NULL
%	NULL
)	NULL
of	NULL
the	NULL
84	NULL
nonleukemic	NULL
samples	NULL
were	NULL
heterozygous	NULL
for	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
marker	NULL
.	NULL

671	NULL
104	NULL
109	NULL
14	NULL
l119	NULL
Fig	NULL
5	NULL
.	NULL

-	NULL
Biallelic	NULL
TAL	NULL
1	NULL
expression	NULL
in	NULL
BM	NULL
cells	NULL
of	NULL
a	NULL
normal	NULL
individual	NULL
.	NULL

Genomic	NULL
DNA	NULL
and	NULL
cDNA	NULL
were	NULL
prepared	NULL
from	NULL
BM	NULL
cells	NULL
of	NULL
a	NULL
normal	NULL
individual	NULL
who	NULL
is	NULL
heterozygous	NULL
for	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
.	NULL

,	NULL
,	NULL
marker	NULL
of	NULL
TAL1	NULL
.	NULL

The	NULL
genomic	NULL
DNA	NULL
and	NULL
cDNA	NULL
were	NULL
amplified	NULL
in	NULL
parallel	NULL
with	NULL
oligonucleotides	NULL
flanking	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
.	NULL

,	NULL
,	NULL
marker	NULL
(	NULL
PM2	NULL
and	NULL
fluorescenated	NULL
PM3	NULL
)	NULL
.	NULL

After	NULL
fractionation	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
373A	NULL
DNA	NULL
Sequencer	NULL
,	NULL
the	NULL
fluorescent	NULL
profiles	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
amplified	NULL
from	NULL
the	NULL
genomic	NULL
DNA	NULL
(	NULL
dashed	NULL
line	NULL
)	NULL
and	NULL
cDNA	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
were	NULL
aligned	NULL
by	NULL
comparison	NULL
with	NULL
internal	NULL
sizing	NULL
markers	NULL
.	NULL

Fluorescent	NULL
intensity	NULL
is	NULL
displayed	NULL
on	NULL
the	NULL
Y-axis	NULL
.	NULL

The	NULL
X-axis	NULL
is	NULL
marked	NULL
with	NULL
DNA	NULL
lengths	NULL
(	NULL
in	NULL
nucleotides	NULL
)	NULL
calculated	NULL
from	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
internal	NULL
GENESCAN	NULL
2500	NULL
sizing	NULL
standards	NULL
.	NULL

Parallel	NULL
peaks	NULL
corresponding	NULL
to	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
and	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
alleles	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
PCR	NULL
products	NULL
of	NULL
both	NULL
the	NULL
genomic	NULL
DNA	NULL
and	NULL
cDNA	NULL
reactions	NULL
,	NULL
indicating	NULL
biallelic	NULL
transcription	NULL
of	NULL
the	NULL
TAL1	NULL
gene	NULL
.	NULL

showed	NULL
TAL1	NULL
transcripts	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
from	NULL
15	NULL
of	NULL
the	NULL
21	NULL
patients	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
15	NULL
patients	NULL
,	NULL
8	NULL
also	NULL
harbored	NULL
tumor-specific	NULL
DNA	NULL
rearrangements	NULL
of	NULL
the	NULL
TAL	NULL
]	NULL
gene	NULL
(	NULL
patients	NULL
no	NULL
.	NULL

1	NULL
,	NULL
19	NULL
,	NULL
23	NULL
,	NULL
26	NULL
,	NULL
28	NULL
,	NULL
30	NULL
,	NULL
34	NULL
,	NULL
and	NULL
37	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
leukemic	NULL
RNA	NULL
from	NULL
each	NULL
of	NULL
the	NULL
8	NULL
patients	NULL
was	NULL
converted	NULL
to	NULL
cDNA	NULL
and	NULL
was	NULL
PCR-amplified	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
patient	NULL
's	NULL
corresponding	NULL
genomic	NULL
DNA	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

A	NULL
fluorescent	NULL
pattern	NULL
indicative	NULL
of	NULL
monoallelic	NULL
transcription	NULL
was	NULL
generated	NULL
from	NULL
each	NULL
of	NULL
the	NULL
8	NULL
leukemia	NULL
specimens	NULL
bearing	NULL
a	NULL
detectable	NULL
TAL	NULL
]	NULL
gene	NULL
rearrangement	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
leukemic	NULL
DNAs	NULL
of	NULL
patients	NULL
no	NULL
.	NULL

19	NULL
,	NULL
23	NULL
,	NULL
26	NULL
,	NULL
and	NULL
34	NULL
are	NULL
heterozygous	NULL
,	NULL
each	NULL
possessing	NULL
both	NULL
a	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
and	NULL
a	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
allele	NULL
of	NULL
TALI	NULL
(	NULL
dashed	NULL
lines	NULL
in	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
shadow	NULL
bands	NULL
,	NULL
it	NULL
is	NULL
apparent	NULL
that	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
no	NULL
.	NULL

23	NULL
and	NULL
26	NULL
express	NULL
transcripts	NULL
primarily	NULL
from	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
,	NULL
;	NULL
allele	NULL
,	NULL
whereas	NULL
those	NULL
of	NULL
patients	NULL
no	NULL
.	NULL

19	NULL
and	NULL
34	NULL
primarily	NULL
express	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
allele	NULL
(	NULL
solid	NULL
lines	NULL
in	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

Monoallelic	NULL
or	NULL
biallelic	NULL
TAL1	NULL
expression	NULL
in	NULL
T-ALL	NULL
cells	NULL
without	NULL
a	NULL
rearranged	NULL
TAL1	NULL
gene	NULL
.	NULL

-	NULL
Of	NULL
the	NULL
15	NULL
heterozygous	NULL
patients	NULL
that	NULL
expressed	NULL
TALI	NULL
,	NULL
7	NULL
did	NULL
not	NULL
harbor	NULL
an	NULL
obvious	NULL
TAL	NULL
]	NULL
gene	NULL
rearrangement	NULL
(	NULL
patients	NULL
no	NULL
.	NULL

8	NULL
,	NULL
20	NULL
,	NULL
24	NULL
,	NULL
29	NULL
,	NULL
32	NULL
,	NULL
33	NULL
,	NULL
and	NULL
36	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
allelic	NULL
origin	NULL
of	NULL
TAL	NULL
]	NULL
transcripts	NULL
in	NULL
these	NULL
patients	NULL
,	NULL
cDNA	NULL
and	NULL
genomic	NULL
DNA	NULL
from	NULL
each	NULL
leukemic	NULL
672	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

A16	NULL
8	NULL
LO8	NULL
|	NULL
.	NULL

BASH	NULL
ET	NULL
AL	NULL
A18	NULL
6	NULL
A16	NULL
_	NULL
6	NULL
106	NULL
J16	NULL
#	NULL
19	NULL
#	NULL
23	NULL
J	NULL
Laz	NULL
#	NULL
26	NULL
#	NULL
34	NULL
/	NULL
w	NULL
a	NULL
wen	NULL
``	NULL
,	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Monoallelic	NULL
TAL1	NULL
expression	NULL
in	NULL
leukemic	NULL
cells	NULL
bearing	NULL
a	NULL
rearranged	NULL
TAL1	NULL
gene	NULL
.	NULL

The	NULL
genomic	NULL
DNA	NULL
and	NULL
cDNA	NULL
of	NULL
each	NULL
patient	NULL
were	NULL
amplified	NULL
in	NULL
parallel	NULL
with	NULL
oligonucteotides	NULL
flanking	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
>	NULL
.	NULL

,	NULL
,	NULL
marker	NULL
of	NULL
TAL	NULL
;	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
analyzed	NULL
and	NULL
displayed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
5	NULL
.	NULL

In	NULL
each	NULL
case	NULL
only	NULL
a	NULL
single	NULL
allele	NULL
of	NULL
TALT	NULL
is	NULL
represented	NULL
among	NULL
the	NULL
PCR	NULL
products	NULL
of	NULL
the	NULL
cDNA	NULL
reaction	NULL
,	NULL
indicating	NULL
monoallelic	NULL
transcription	NULL
of	NULL
the	NULL
TALT	NULL
gene	NULL
.	NULL

specimen	NULL
were	NULL
PCR-amplified	NULL
in	NULL
parallel	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Fig	NULL
7A	NULL
,	NULL
3	NULL
patients	NULL
showed	NULL
a	NULL
monoallelic	NULL
pattern	NULL
of	NULL
TAL	NULL
]	NULL
/	NULL
The	NULL
fluorescent	NULL
profiles	NULL
obtained	NULL
by	NULL
amplification	NULL
of	NULL
the	NULL
ge-	NULL
transcription	NULL
in	NULL
which	NULL
expression	NULL
was	NULL
restricted	NULL
to	NULL
either	NULL
the	NULL
nomic	NULL
DNAs	NULL
confirmed	NULL
that	NULL
each	NULL
of	NULL
these	NULL
patients	NULL
harbored	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
allele	NULL
(	NULL
patients	NULL
no	NULL
.	NULL

32	NULL
and	NULL
33	NULL
)	NULL
or	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
allele	NULL
both	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
and	NULL
(	NULL
TG	NULL
)	NULL
;	NULL
;	NULL
alleles	NULL
.	NULL

However	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
(	NULL
patient	NULL
no	NULL
.	NULL

29	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
alleles	NULL
were	NULL
expressed	NULL
in	NULL
Â£96	NULL
,	NULL
J16	NULL
29	NULL
jo9	NULL
A19	NULL
__	NULL
or	NULL
J97	NULL
A17	NULL
A	NULL
#	NULL
32	NULL
Fig	NULL
7	NULL
.	NULL

-	NULL
Allelic	NULL
patterns	NULL
of	NULL
TALT	NULL
expression	NULL
in	NULL
le	NULL
of	NULL
each	NULL
patient	NULL
were	NULL
amplified	NULL
in	NULL
parallel	NULL
with	NULL
oli	NULL
ukemic	NULL
cells	NULL
without	NULL
a	NULL
detectable	NULL
TAL1	NULL
gene	NULL
rearrangement	NULL
.	NULL

The	NULL
genomic	NULL
DNA	NULL
and	NULL
cDNA	NULL
gonucieotides	NULL
flanking	NULL
the	NULL
(	NULL
TG	NULL
)	NULL
Â»	NULL
,	NULL
marker	NULL
of	NULL
TAL1	NULL
;	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
analyzed	NULL
and	NULL
displayed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Monoalielic	NULL
TAL	NULL
!	NULL

expression	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
no	NULL
.	NULL

29	NULL
,	NULL
32	NULL
,	NULL
and	NULL
33	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Biallelic	NULL
TAL	NULL
T	NULL
expression	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
no	NULL
.	NULL

8	NULL
,	NULL
20	NULL
,	NULL
24	NULL
,	NULL
and	NULL
36	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ACTIVATION	NULL
OF	NULL
THE	NULL
TAL	NULL
?	NULL

GENE	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
no	NULL
.	NULL

8	NULL
,	NULL
20	NULL
,	NULL
24	NULL
,	NULL
and	NULL
36	NULL
(	NULL
Fig	NULL
7B	NULL
)	NULL
.	NULL

RT-PCR	NULL
artifacts	NULL
are	NULL
unlikely	NULL
to	NULL
account	NULL
for	NULL
these	NULL
biallelic	NULL
patterns	NULL
,	NULL
because	NULL
such	NULL
patterns	NULL
were	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
8	NULL
leukemia	NULL
specimens	NULL
bearing	NULL
a	NULL
detectable	NULL
TALI	NULL
gene	NULL
rearrangement	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
TAL	NULL
]	NULL
transcription	NULL
occurs	NULL
in	NULL
either	NULL
a	NULL
monoallelic	NULL
or	NULL
a	NULL
biallelic	NULL
manner	NULL
in	NULL
T-ALL	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
have	NULL
obvious	NULL
TALI	NULL
gene	NULL
rearrangements	NULL
.	NULL

Does	NULL
TALL	NULL
gene	NULL
activation	NULL
occur	NULL
in	NULL
a	NULL
majority	NULL
of	NULL
T-ALL	NULL
patients	NULL
?	NULL

-	NULL
Almost	NULL
25	NULL
%	NULL
of	NULL
T-ALL	NULL
patients	NULL
harbor	NULL
tumor-specific	NULL
DNA	NULL
rearrangements	NULL
that	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
TALI	NULL
locus	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
TALL	NULL
expression	NULL
occurs	NULL
in	NULL
the	NULL
malignant	NULL
cells	NULL
of	NULL
more	NULL
than	NULL
60	NULL
%	NULL
of	NULL
T-ALL	NULL
patients	NULL
,	NULL
including	NULL
many	NULL
that	NULL
are	NULL
devoid	NULL
of	NULL
obvious	NULL
TAL	NULL
]	NULL
gene	NULL
alterations	NULL
.	NULL

We	NULL
can	NULL
not	NULL
be	NULL
certain	NULL
that	NULL
TAL	NULL
]	NULL
expression	NULL
in	NULL
the	NULL
latter	NULL
subset	NULL
of	NULL
patients	NULL
is	NULL
a	NULL
result	NULL
of	NULL
tumor-specific	NULL
gene	NULL
activation	NULL
.	NULL

Nevertheless	NULL
,	NULL
several	NULL
of	NULL
these	NULL
patients	NULL
(	NULL
no	NULL
.	NULL

29	NULL
,	NULL
32	NULL
,	NULL
and	NULL
33	NULL
)	NULL
show	NULL
a	NULL
monoallelic	NULL
pattern	NULL
of	NULL
TALZ	NULL
expression	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
in	NULL
leukemic	NULL
specimens	NULL
bearing	NULL
a	NULL
detectable	NULL
TAL	NULL
!	NULL

gene	NULL
defect	NULL
.	NULL

Hence	NULL
,	NULL
cis-activation	NULL
of	NULL
TALI	NULL
in	NULL
the	NULL
primary	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
no	NULL
.	NULL

29	NULL
,	NULL
32	NULL
,	NULL
and	NULL
33	NULL
presumably	NULL
results	NULL
from	NULL
more	NULL
subtle	NULL
alterations	NULL
that	NULL
similarly	NULL
affect	NULL
a	NULL
single	NULL
allele	NULL
of	NULL
the	NULL
TALI	NULL
gene	NULL
in	NULL
a	NULL
tumor-specific	NULL
manner	NULL
.	NULL

These	NULL
alterations	NULL
might	NULL
include	NULL
local	NULL
changes	NULL
,	NULL
such	NULL
as	NULL
point	NULL
mutations	NULL
,	NULL
in	NULL
the	NULL
cis-acting	NULL
regulatory	NULL
sequences	NULL
that	NULL
normally	NULL
control	NULL
transcription	NULL
.	NULL

Similarly	NULL
,	NULL
Leroy-Viard	NULL
et	NULL
al	NULL
``	NULL
``	NULL
recently	NULL
reported	NULL
that	NULL
monoallelic	NULL
TAL	NULL
]	NULL
transcription	NULL
also	NULL
occurs	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
an	NULL
established	NULL
T-ALL	NULL
line	NULL
that	NULL
does	NULL
not	NULL
have	NULL
an	NULL
obvious	NULL
alteration	NULL
of	NULL
the	NULL
TAL	NULL
]	NULL
gene	NULL
.	NULL

Biallelic	NULL
TAL	NULL
]	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
leukemic	NULL
673	NULL
cells	NULL
of	NULL
4	NULL
patients	NULL
that	NULL
did	NULL
not	NULL
harbor	NULL
an	NULL
obvious	NULL
TAL	NULL
]	NULL
gene	NULL
rearrangement	NULL
(	NULL
patients	NULL
no	NULL
.	NULL

8	NULL
,	NULL
20	NULL
,	NULL
24	NULL
,	NULL
and	NULL
36	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
mechanism	NULL
of	NULL
TAL	NULL
]	NULL
activation	NULL
in	NULL
this	NULL
subset	NULL
of	NULL
patients	NULL
is	NULL
unclear	NULL
,	NULL
it	NULL
presumably	NULL
involves	NULL
frans-acting	NULL
factors	NULL
that	NULL
can	NULL
induce	NULL
transcription	NULL
of	NULL
both	NULL
TAL	NULL
]	NULL
alleles	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
may	NULL
be	NULL
significant	NULL
that	NULL
several	NULL
presumptive	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
T-ALL	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
TALl-related	NULL
bHLH	NULL
proteins	NULL
(	NULL
TAL1	NULL
,	NULL
TAL2	NULL
,	NULL
and	NULL
LYL1	NULL
)	NULL
,	NULL
these	NULL
include	NULL
bHLH-zipper	NULL
(	NULL
c-MYC	NULL
)	NULL
,	NULL
``	NULL
``	NULL
``	NULL
homeodomain	NULL
(	NULL
HOX-11	NULL
)	NULL
,	NULL
***	NULL
and	NULL
LIM	NULL
(	NULL
RBTN1/TTG1	NULL
and	NULL
RBTN2	NULL
)	NULL
**	NULL
polypeptides	NULL
that	NULL
are	NULL
also	NULL
activated	NULL
by	NULL
tumor-specific	NULL
chromosome	NULL
translocations	NULL
.	NULL

Some	NULL
of	NULL
these	NULL
factors	NULL
may	NULL
have	NULL
the	NULL
ability	NULL
to	NULL
induce	NULL
TAL	NULL
]	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
presumably	NULL
in	NULL
a	NULL
biallelic	NULL
fashion	NULL
such	NULL
as	NULL
that	NULL
observed	NULL
in	NULL
patients	NULL
no	NULL
.	NULL

20	NULL
,	NULL
24	NULL
,	NULL
and	NULL
36	NULL
.	NULL

Although	NULL
TALI	NULL
activation	NULL
would	NULL
not	NULL
be	NULL
the	NULL
primary	NULL
genetic	NULL
lesion	NULL
in	NULL
these	NULL
patients	NULL
,	NULL
it	NULL
may	NULL
nonetheless	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
ensuing	NULL
leukemogenesis	NULL
.	NULL

The	NULL
present	NULL
study	NULL
shows	NULL
that	NULL
TALI	NULL
expression	NULL
occurs	NULL
in	NULL
the	NULL
malignant	NULL
cells	NULL
of	NULL
most	NULL
T-ALL	NULL
patients	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
common	NULL
cytogenetic	NULL
defect	NULL
,	NULL
a	NULL
majority	NULL
of	NULL
T-ALL	NULL
patients	NULL
(	NULL
>	NULL
60	NULL
%	NULL
)	NULL
show	NULL
transcriptional	NULL
activation	NULL
of	NULL
either	NULL
TALI	NULL
or	NULL
the	NULL
related	NULL
genes	NULL
TAL2	NULL
and	NULL
LYL1I	NULL
.	NULL

Future	NULL
studies	NULL
will	NULL
be	NULL
required	NULL
to	NULL
ascertain	NULL
whether	NULL
the	NULL
remaining	NULL
T-ALL	NULL
patients	NULL
harbor	NULL
other	NULL
genetic	NULL
lesions	NULL
equivalent	NULL
to	NULL
TALL	NULL
]	NULL
activation	NULL
,	NULL
or	NULL
whether	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
these	NULL
patients	NULL
represent	NULL
a	NULL
distinct	NULL
clinical	NULL
subtype	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Yu	NULL
Yan	NULL
Liu	NULL
,	NULL
Li	NULL
Meng	NULL
,	NULL
and	NULL
Julia	NULL
Tsou	NULL
Tsan	NULL
for	NULL
technical	NULL
assistance	NULL
and	NULL
Susan	NULL
Campbell	NULL
for	NULL
preparing	NULL
the	NULL
manuscript	NULL
.	NULL

APPENDIX	NULL
Contributing	NULL
Institutions	NULL
Institution	NULL
PI	NULL
Grant	NULL
No	NULL
.	NULL

Alberta	NULL
Pediatric	NULL
Oncology	NULL
Consortium	NULL
,	NULL
Edmonton	NULL
,	NULL
Canada	NULL
Ronald	NULL
Grant	NULL
CA-53490	NULL
All	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
St	NULL
Petersburgh	NULL
,	NULL
FL	NULL
Jerry	NULL
Barbosa	NULL
Baylor	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
Philip	NULL
Steuber	NULL
CA-03161	NULL
Boston	NULL
Floating	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
Cynthia	NULL
Kretschmar	NULL
CA-53549	NULL
Bowman	NULL
Gray	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Winston	NULL
,	NULL
Salem	NULL
,	NULL
NC	NULL
Allen	NULL
Chauvenet	NULL
CA-53128	NULL
Brooke	NULL
Army	NULL
Medical	NULL
Center	NULL
,	NULL
Ft	NULL
Sam	NULL
Houston	NULL
,	NULL
TX	NULL
Terry	NULL
Pick	NULL
CA-28752	NULL
Carolinas	NULL
Medical	NULL
Center	NULL
,	NULL
Charlotte	NULL
,	NULL
NC	NULL
Barry	NULL
Golembe	NULL
CA-15525	NULL
Cook	NULL
County	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
Sudha	NULL
Rao	NULL
CA-07431	NULL
Children	NULL
's	NULL
Hospital	NULL
and	NULL
Health	NULL
Center	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
Richard	NULL
Kadota	NULL
CA-28439	NULL
Children	NULL
's	NULL
Hospital	NULL
Greenville	NULL
Health	NULL
Systems	NULL
,	NULL
Greenville	NULL
,	NULL
SC	NULL
Cary	NULL
Stroud	NULL
CA-53128	NULL
Children	NULL
's	NULL
Hospital	NULL
of	NULL
Michigan	NULL
,	NULL
Detroit	NULL
,	NULL
MI	NULL
Y.	NULL
Ravindranath	NULL
CA-29691	NULL
Children	NULL
's	NULL
Hospital	NULL
of	NULL
New	NULL
Orleans	NULL
,	NULL
LA	NULL
Rafael	NULL
Ducos	NULL
Children	NULL
's	NULL
Memorial	NULL
Hospital	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
Morris	NULL
Kletzel	NULL
CA-07431	NULL
Christ	NULL
Hospital	NULL
and	NULL
Medical	NULL
Center	NULL
,	NULL
Oak	NULL
Lawn	NULL
,	NULL
IL	NULL
Sharad	NULL
Salvi	NULL
CA-07431	NULL
City	NULL
of	NULL
Hope	NULL
National	NULL
Medical	NULL
Center	NULL
,	NULL
Duarte	NULL
,	NULL
CA	NULL
Robert	NULL
Chilcote	NULL
CA-32278	NULL
Cook-Ft	NULL
Worth	NULL
Children	NULL
's	NULL
Medical	NULL
Center	NULL
,	NULL
Ft.	NULL
Worth	NULL
,	NULL
TX	NULL
Paul	NULL
Bowman	NULL
CA-33625	NULL
Cross	NULL
Cancer	NULL
Institute	NULL
,	NULL
Alberta	NULL
,	NULL
Canada	NULL
Paul	NULL
Grundy	NULL
CA-53490	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
Holcombe	NULL
Grier	NULL
CA-41573	NULL
Dartmouth-Hitchcock	NULL
Medical	NULL
Center	NULL
,	NULL
Lebanon	NULL
,	NULL
NH	NULL
Eric	NULL
Larsen	NULL
CA-29293	NULL
Duke	NULL
University	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
John	NULL
Falletta	NULL
CA-15525	NULL
Eastern	NULL
Maine	NULL
Medical	NULL
Center	NULL
,	NULL
Bangor	NULL
,	NULL
ME	NULL
Sam	NULL
Lew	NULL
CA-53549	NULL
East	NULL
Carolina	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Greenville	NULL
,	NULL
NC	NULL
Tate	NULL
Holbrook	NULL
CA-15515	NULL
Emory	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Atlanta	NULL
,	NULL
GA	NULL
Andrew	NULL
Yeager	NULL
CA-20549	NULL
Fairfax	NULL
Hospital	NULL
,	NULL
Falls	NULL
Church	NULL
,	NULL
VA	NULL
Jay	NULL
Greenberg	NULL
CA-28476	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

674	NULL
Hackensack	NULL
Medical	NULL
Center	NULL
,	NULL
Hackensack	NULL
,	NULL
NJ	NULL
Hurley	NULL
Medical	NULL
Center	NULL
,	NULL
Flint	NULL
,	NULL
MI	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
Keesler	NULL
Air	NULL
Force	NULL
Medical	NULL
Center	NULL
,	NULL
Biloxi	NULL
,	NULL
MS	NULL
Kaiser	NULL
Permanente	NULL
Medical	NULL
Center	NULL
,	NULL
Santa	NULL
Clara	NULL
,	NULL
CA	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
Medical	NULL
University	NULL
of	NULL
South	NULL
Carolina	NULL
,	NULL
Charleston	NULL
,	NULL
SC	NULL
McGill	NULL
University	NULL
,	NULL
Montreal	NULL
,	NULL
Canada	NULL
Medical	NULL
College	NULL
of	NULL
Virginia	NULL
,	NULL
Richmond	NULL
,	NULL
VA	NULL
Memorial	NULL
Hospital	NULL
of	NULL
Hollywood	NULL
,	NULL
Hollywood	NULL
,	NULL
CA	NULL
Miami	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Miami	NULL
,	NULL
FL	NULL
Midwest	NULL
Children	NULL
's	NULL
Cancer	NULL
Center	NULL
,	NULL
Milwaukee	NULL
,	NULL
WI	NULL
Mount	NULL
Sinai	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
Naval	NULL
Regional	NULL
Medical	NULL
Center	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
Nemours	NULL
Children	NULL
's	NULL
Clinic	NULL
,	NULL
Jacksonville	NULL
,	NULL
FL	NULL
Oklahoma	NULL
University	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Oklahoma	NULL
City	NULL
,	NULL
OK	NULL
Orlando	NULL
Cancer	NULL
Center	NULL
,	NULL
Orlando	NULL
,	NULL
FL	NULL
Rhode	NULL
Island	NULL
Hospital	NULL
,	NULL
Providence	NULL
,	NULL
RI	NULL
Roswell	NULL
Park	NULL
Memorial	NULL
Institute	NULL
,	NULL
Buffalo	NULL
,	NULL
NY	NULL
Rush-Presbyterian-St	NULL
Luke	NULL
's	NULL
Medical	NULL
Center	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
Sacred	NULL
Heart	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Pensacola	NULL
,	NULL
FL	NULL
St	NULL
John	NULL
Hospital	NULL
,	NULL
Detroit	NULL
,	NULL
MI	NULL
St	NULL
Joseph	NULL
's	NULL
Cancer	NULL
Institute	NULL
,	NULL
Tampa	NULL
,	NULL
FL	NULL
St	NULL
Jude	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
St	NULL
Christopher	NULL
Hospital	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
St	NULL
Francis	NULL
Regional	NULL
Medical	NULL
Center	NULL
,	NULL
Wichita	NULL
,	NULL
KS	NULL
St	NULL
Vincent	NULL
Hospital	NULL
,	NULL
Green	NULL
Bay	NULL
,	NULL
WI	NULL
Scott	NULL
&	NULL
White	NULL
Memorial	NULL
Hospital	NULL
,	NULL
Temple	NULL
,	NULL
TX	NULL
Stanford	NULL
University	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
State	NULL
University	NULL
of	NULL
New	NULL
York	NULL
,	NULL
Syracuse	NULL
,	NULL
NY	NULL
Swiss	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
,	NULL
Bern	NULL
,	NULL
Switzerland	NULL
University	NULL
of	NULL
Alabama	NULL
,	NULL
Birmingham	NULL
,	NULL
AL	NULL
University	NULL
of	NULL
Arizona	NULL
,	NULL
Tucson	NULL
,	NULL
AZ	NULL
University	NULL
of	NULL
Arkansas	NULL
,	NULL
Little	NULL
Rock	NULL
,	NULL
AR	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Davis	NULL
,	NULL
Sacramento	NULL
,	NULL
CA	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
University	NULL
of	NULL
Florida	NULL
,	NULL
Shands	NULL
Teaching	NULL
Hospital	NULL
,	NULL
Gainesville	NULL
,	NULL
FL	NULL
University	NULL
of	NULL
Kansas	NULL
,	NULL
Kansas	NULL
City	NULL
,	NULL
MO	NULL
University	NULL
of	NULL
Maryland	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
University	NULL
of	NULL
Miami	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Miami	NULL
,	NULL
FL	NULL
University	NULL
of	NULL
Mississippi	NULL
Medical	NULL
Center	NULL
,	NULL
Jackson	NULL
,	NULL
MS	NULL
University	NULL
of	NULL
Missouri	NULL
,	NULL
Columbia	NULL
,	NULL
MO	NULL
University	NULL
of	NULL
Rochester	NULL
Medical	NULL
Center	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
University	NULL
of	NULL
South	NULL
Alabama	NULL
,	NULL
Mobile	NULL
,	NULL
AL	NULL
University	NULL
of	NULL
South	NULL
Florida	NULL
,	NULL
Tampa	NULL
,	NULL
FL	NULL
University	NULL
of	NULL
Texas-Galveston	NULL
,	NULL
Galveston	NULL
,	NULL
TX	NULL
University	NULL
of	NULL
Texas-Southwestern	NULL
Medical	NULL
School	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
University	NULL
of	NULL
Texas	NULL
,	NULL
San	NULL
Antonio	NULL
,	NULL
TX	NULL
University	NULL
of	NULL
Vermont	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Burlington	NULL
,	NULL
VT	NULL
Walter	NULL
Reed	NULL
Army	NULL
Medical	NULL
Center	NULL
,	NULL
Washington	NULL
,	NULL
DC	NULL
Warren	NULL
Clinics	NULL
,	NULL
Inc	NULL
,	NULL
Tulsa	NULL
,	NULL
OK	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
West	NULL
Virginia	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Charleston	NULL
,	NULL
WV	NULL
W.	NULL
Virginia	NULL
University	NULL
Health	NULL
Services	NULL
Center	NULL
,	NULL
Morgantown	NULL
,	NULL
WV	NULL
Wilford	NULL
Hall	NULL
USAF	NULL
Medical	NULL
Center	NULL
,	NULL
Lackland	NULL
AFB	NULL
,	NULL
TX	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
Michael	NULL
Harris	NULL
Susumu	NULL
Inoue	NULL
Cindy	NULL
Schwartz	NULL
Thomas	NULL
Abshire	NULL
Lily	NULL
Young	NULL
William	NULL
Ferguson	NULL
Joseph	NULL
Laver	NULL
Michael	NULL
Whitehead	NULL
E.	NULL
Clifton	NULL
Russell	NULL
Phillipa	NULL
Sprinz	NULL
Enrique	NULL
Escalon	NULL
Bruce	NULL
Camitta	NULL
Jeffrey	NULL
Lipton	NULL
David	NULL
Reardon	NULL
Paul	NULL
Pitel	NULL
Ruprecht	NULL
Nitschke	NULL
Vincent	NULL
Giusti	NULL
Edwin	NULL
Forman	NULL
Martin	NULL
Brecher	NULL
Alexander	NULL
Green	NULL
Thomas	NULL
Jenkins	NULL
Hadi	NULL
Sawaf	NULL
Cameron	NULL
Tebbi	NULL
Ching-Hon	NULL
Pui	NULL
Edwin	NULL
Douglass	NULL
David	NULL
Rosen	NULL
Dorothy	NULL
Ganick	NULL
Lawrence	NULL
Frankel	NULL
Michael	NULL
Link	NULL
Ronald	NULL
Dubowy	NULL
Hans	NULL
Wagner	NULL
Robert	NULL
Castleberry	NULL
John	NULL
Hutter	NULL
David	NULL
Becton	NULL
Jonathan	NULL
Ducore	NULL
Faith	NULL
Kung	NULL
Paulette	NULL
Mehta	NULL
Tribhawan	NULL
Vats	NULL
Christopher	NULL
Frantz	NULL
Stuart	NULL
Toledano	NULL
Jeanette	NULL
Pullen	NULL
Narollah	NULL
Hakami	NULL
Reggie	NULL
Duerst	NULL
Yih-Ming	NULL
Yang	NULL
Eva	NULL
Hvizdala	NULL
Mary	NULL
Haggard	NULL
George	NULL
Buchanan	NULL
Paul	NULL
Jon	NULL
Thomas	NULL
Joseph	NULL
Dickerman	NULL
David	NULL
Maybee	NULL
Gregory	NULL
Kirkpatrick	NULL
Teresa	NULL
Vietti	NULL
Kenneth	NULL
Starling	NULL
A.	NULL
Kim	NULL
Ritchey	NULL
Tanya	NULL
Trippet	NULL
Jack	NULL
Van	NULL
Hoff	NULL
BASH	NULL
ET	NULL
AL	NULL
CA-29691	NULL
CA-28476	NULL
CA-15989	NULL
CA-33603	NULL
CA-29293	NULL
CA-16388	NULL
CA-33587	NULL
CA-28530	NULL
CA-29281	NULL
CA-32053	NULL
CA-38859	NULL
CA-28439	NULL
CA-29281	NULL
CA-11233	NULL
CA-29293	NULL
CA-28383	NULL
CA-07431	NULL
CA-29691	NULL
CA-31566	NULL
CA-45261	NULL
CA-35431	NULL
CA-32053	NULL
CA-33625	NULL
CA-33603	NULL
CA-28383	NULL
CA-53301	NULL
CA-25408	NULL
CA-41188	NULL
CA-41188	NULL
CA-58967	NULL
CA-28439	NULL
CA-29281	NULL
CA-28841	NULL
CA-28476	NULL
CA-41082	NULL
CA-15989	NULL
CA-05587	NULL
CA-41573	NULL
CA-03161	NULL
CA-33625	NULL
CA-52771	NULL
CA-29293	NULL
CA-28752	NULL
CA-11233	NULL
CA-05587	NULL
CA-15525	NULL
CA-15525	NULL
CA-52317	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ACTIVATION	NULL
OF	NULL
THE	NULL
TAL	NULL
?	NULL

GENE	NULL
REFERENCES	NULL
1	NULL
.	NULL

Nowell	NULL
PC	NULL
,	NULL
Hungerford	NULL
DA	NULL
:	NULL
A	NULL
minute	NULL
chromosome	NULL
in	NULL
human	NULL
chronic	NULL
granulocytic	NULL
leukemia	NULL
.	NULL

Science	NULL
132:1497	NULL
,	NULL
1960	NULL
2	NULL
.	NULL

Rowley	NULL
JD	NULL
:	NULL
A	NULL
new	NULL
consistent	NULL
chromosomal	NULL
abnormality	NULL
in	NULL
chronic	NULL
myelogenous	NULL
luekemia	NULL
identified	NULL
by	NULL
quinacrine	NULL
fluorescence	NULL
and	NULL
Giemsa	NULL
staining	NULL
.	NULL

Nature	NULL
243:290	NULL
,	NULL
1973	NULL
3	NULL
.	NULL

Rabbitts	NULL
TH	NULL
:	NULL
Translocations	NULL
,	NULL
master	NULL
genes	NULL
,	NULL
and	NULL
differences	NULL
between	NULL
the	NULL
origins	NULL
of	NULL
acute	NULL
and	NULL
chronic	NULL
leukemias	NULL
.	NULL

Cell	NULL
67:641	NULL
,	NULL
1991	NULL
4	NULL
.	NULL

Korsmeyer	NULL
SJ	NULL
:	NULL
;	NULL
Chromosomal	NULL
translocations	NULL
in	NULL
lymphoid	NULL
malignancies	NULL
reveal	NULL
novel	NULL
proto-oncognes	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
10:785	NULL
,	NULL
1992	NULL
5	NULL
.	NULL

Rabbitts	NULL
TH	NULL
:	NULL
Chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
cancer	NULL
.	NULL

Nature	NULL
372:143	NULL
,	NULL
1994	NULL
6	NULL
.	NULL

Rubin	NULL
CM	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
:	NULL
Cytogenetic	NULL
abnormalities	NULL
in	NULL
childhood	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Am	NULL
J	NULL
Pediatr	NULL
Hematol	NULL
Oncol	NULL
13:202	NULL
,	NULL
1991	NULL
7	NULL
.	NULL

Raimondi	NULL
SC	NULL
:	NULL
Current	NULL
status	NULL
of	NULL
cytogenetic	NULL
research	NULL
in	NULL
childhood	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Blood	NULL
81:2237	NULL
,	NULL
1993	NULL
8	NULL
.	NULL

Chen	NULL
Q	NULL
,	NULL
Cheng	NULL
J-T	NULL
,	NULL
Tsai	NULL
L-H	NULL
,	NULL
Schneider	NULL
N	NULL
,	NULL
Buchanan	NULL
G	NULL
,	NULL
Carroll	NULL
A	NULL
,	NULL
Crist	NULL
W	NULL
,	NULL
Ozanne	NULL
B	NULL
,	NULL
Siciliano	NULL
MJ	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
The	NULL
tal	NULL
gene	NULL
undergoes	NULL
chromosome	NULL
translocation	NULL
in	NULL
T	NULL
cell	NULL
leukemia	NULL
and	NULL
potien-tially	NULL
encodes	NULL
a	NULL
helix-loop-helix	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
9:415	NULL
,	NULL
1990	NULL
9	NULL
.	NULL

Chen	NULL
Q	NULL
,	NULL
Yang	NULL
CY-C	NULL
,	NULL
Tsan	NULL
JT	NULL
,	NULL
Xia	NULL
Y	NULL
,	NULL
Ragab	NULL
AH	NULL
,	NULL
Peiper	NULL
SC	NULL
,	NULL
Carroll	NULL
A	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Coding	NULL
sequences	NULL
of	NULL
the	NULL
tal-1	NULL
gene	NULL
are	NULL
disrupted	NULL
by	NULL
chromosome	NULL
translocation	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1721403	NULL
,	NULL
1990	NULL
10	NULL
.	NULL

Bernard	NULL
O	NULL
,	NULL
Guglielmi	NULL
P	NULL
,	NULL
Jonveaux	NULL
P	NULL
,	NULL
Cherif	NULL
D	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
,	NULL
Mauchauffe	NULL
M	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Larsen	NULL
C-J	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
Two	NULL
distict	NULL
mechanisms	NULL
for	NULL
the	NULL
SCL	NULL
gene	NULL
activation	NULL
in	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
of	NULL
T-cell	NULL
leukemias	NULL
.	NULL

Genes	NULL
Chromosom	NULL
Cancer	NULL
1:194	NULL
,	NULL
1990	NULL
11	NULL
.	NULL

Finger	NULL
LR	NULL
,	NULL
Kagan	NULL
J	NULL
,	NULL
Christopher	NULL
G	NULL
,	NULL
Kurtzberg	NULL
J	NULL
,	NULL
Hershfield	NULL
MS	NULL
,	NULL
Nowell	NULL
PC	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
TCLS	NULL
gene	NULL
on	NULL
human	NULL
chromosome	NULL
1	NULL
in	NULL
T-cell	NULL
leukemia	NULL
and	NULL
melanoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:5039	NULL
,	NULL
1989	NULL
12	NULL
.	NULL

Begley	NULL
CG	NULL
,	NULL
Aplan	NULL
PD	NULL
,	NULL
Denning	NULL
SM	NULL
,	NULL
Haynes	NULL
BF	NULL
,	NULL
Waldmann	NULL
TA	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
The	NULL
gene	NULL
SCL	NULL
is	NULL
expressed	NULL
during	NULL
early	NULL
hematopoie-sis	NULL
and	NULL
encodes	NULL
a	NULL
differentiation-related	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:10128	NULL
,	NULL
1989	NULL
13	NULL
.	NULL

Carroll	NULL
AJ	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Link	NULL
MP	NULL
,	NULL
Amylon	NULL
MD	NULL
,	NULL
Pullen	NULL
DJ	NULL
,	NULL
Ragab	NULL
AH	NULL
,	NULL
Buchanan	NULL
GR	NULL
,	NULL
Wimmer	NULL
RS	NULL
,	NULL
Viet	NULL
TJ	NULL
;	NULL
The	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p34	NULL
;	NULL
q11	NULL
)	NULL
is	NULL
nonrandom	NULL
and	NULL
restricted	NULL
to	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
:	NULL
A	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
Study	NULL
.	NULL

Blood	NULL
76:1220	NULL
,	NULL
1990	NULL
14	NULL
.	NULL

Brown	NULL
L	NULL
,	NULL
Cheng	NULL
J-T	NULL
,	NULL
Chen	NULL
Q	NULL
,	NULL
Siciliano	NULL
MJ	NULL
,	NULL
Crist	NULL
W	NULL
,	NULL
Buchanan	NULL
G	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Site-specific	NULL
recombination	NULL
of	NULL
the	NULL
ral-1	NULL
gene	NULL
is	NULL
a	NULL
common	NULL
occurrence	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

EMBO	NULL
J	NULL
9:3343	NULL
,	NULL
1990	NULL
15	NULL
.	NULL

Bernard	NULL
O	NULL
,	NULL
Lecointe	NULL
N	NULL
,	NULL
Jonveaux	NULL
P	NULL
,	NULL
Souyri	NULL
M	NULL
,	NULL
Mauchauffe	NULL
M	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Larson	NULL
CJ	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
Two	NULL
site-specific	NULL
deletions	NULL
and	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
restricted	NULL
to	NULL
human	NULL
T-cell	NULL
acute	NULL
leuke-mias	NULL
disrupt	NULL
the	NULL
5	NULL
'	NULL
part	NULL
of	NULL
the	NULL
tal-7	NULL
gene	NULL
.	NULL

Oncogene	NULL
6:1477	NULL
,	NULL
1991	NULL
16	NULL
.	NULL

Aplan	NULL
PD	NULL
,	NULL
Lombardi	NULL
DP	NULL
,	NULL
Reaman	NULL
GH	NULL
,	NULL
Sather	NULL
HN	NULL
,	NULL
Hammond	NULL
GD	NULL
,	NULL
Krisch	NULL
IR	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
putative	NULL
hematopoietic	NULL
transcription	NULL
factor	NULL
SCL	NULL
in	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Blood	NULL
79:1327	NULL
,	NULL
1992	NULL
17	NULL
.	NULL

Bash	NULL
RO	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Shuster	NULL
JJ	NULL
,	NULL
Link	NULL
MP	NULL
,	NULL
Amylon	NULL
M	NULL
,	NULL
Pullen	NULL
J	NULL
,	NULL
Carroll	NULL
AJ	NULL
,	NULL
Buchanan	NULL
GR	NULL
,	NULL
Smith	NULL
RG	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Clinical	NULL
features	NULL
and	NULL
outcome	NULL
of	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
in	NULL
childhood	NULL
with	NULL
respect	NULL
to	NULL
alterations	NULL
at	NULL
the	NULL
TALZ	NULL
locus	NULL
:	NULL
A	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
Study	NULL
.	NULL

Blood	NULL
81:2110	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

Breit	NULL
TM	NULL
,	NULL
Mol	NULL
EJ	NULL
,	NULL
Wolvers-Tettero	NULL
ILM	NULL
,	NULL
Ludwig	NULL
W-D	NULL
,	NULL
van	NULL
Wering	NULL
ER	NULL
,	NULL
van	NULL
Dongen	NULL
JIM	NULL
:	NULL
Site-specific	NULL
deletions	NULL
involving	NULL
the	NULL
tal-1	NULL
and	NULL
sil	NULL
genes	NULL
are	NULL
restricted	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
a/f	NULL
lineage	NULL
:	NULL
T	NULL
cell	NULL
receptor	NULL
6	NULL
gene	NULL
deletion	NULL
mechanism	NULL
affects	NULL
multiple	NULL
genes	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
177:965	NULL
,	NULL
1993	NULL
675	NULL
19	NULL
.	NULL

Kikuchi	NULL
A	NULL
,	NULL
Hayashi	NULL
Y	NULL
,	NULL
Kobayashi	NULL
S	NULL
,	NULL
Hanada	NULL
R	NULL
,	NULL
Moriwaki	NULL
K	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Fujimoto	NULL
J-i	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Yamamori	NULL
S	NULL
:	NULL
Clinical	NULL
significance	NULL
of	NULL
TAL1	NULL
gene	NULL
alteration	NULL
in	NULL
childhood	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
.	NULL

Leukemia	NULL
7:933	NULL
,	NULL
1993	NULL
20	NULL
.	NULL

Xia	NULL
Y	NULL
,	NULL
Brown	NULL
L	NULL
,	NULL
Yang	NULL
CY-C	NULL
,	NULL
Tsan	NULL
JT	NULL
,	NULL
Siciliano	NULL
MJ	NULL
,	NULL
Es-pinosa	NULL
III	NULL
R	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Baer	NULL
RJ	NULL
:	NULL
TAL2	NULL
,	NULL
a	NULL
helix-loop-helix	NULL
gene	NULL
activated	NULL
by	NULL
the	NULL
(	NULL
7	NULL
;	NULL
9	NULL
)	NULL
(	NULL
q34	NULL
;	NULL
q32	NULL
)	NULL
translocation	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:11416	NULL
,	NULL
1991	NULL
21	NULL
.	NULL

Mellentin	NULL
JD	NULL
,	NULL
Smith	NULL
SC	NULL
,	NULL
Cleary	NULL
ML	NULL
:	NULL
ly/-/	NULL
,	NULL
A	NULL
novel	NULL
gene	NULL
altered	NULL
by	NULL
chromosomal	NULL
translocation	NULL
in	NULL
T	NULL
cell	NULL
leukemia	NULL
,	NULL
codes	NULL
for	NULL
a	NULL
protein	NULL
with	NULL
a	NULL
helix-loop-helix	NULL
DNA	NULL
binding	NULL
motif	NULL
.	NULL

Cell	NULL
58:77	NULL
,	NULL
1989	NULL
22	NULL
.	NULL

Baer	NULL
R	NULL
:	NULL
TAL1	NULL
,	NULL
TAL2	NULL
,	NULL
and	NULL
LYL1	NULL
:	NULL
A	NULL
family	NULL
of	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
implicated	NULL
in	NULL
T	NULL
cell	NULL
acute	NULL
leukaemia	NULL
.	NULL

Semin	NULL
Cancer	NULL
Biol	NULL
4:341	NULL
,	NULL
1993	NULL
23	NULL
.	NULL

Link	NULL
M	NULL
,	NULL
Warnke	NULL
R	NULL
,	NULL
Finlay	NULL
J	NULL
,	NULL
Amylon	NULL
M	NULL
,	NULL
Miller	NULL
R	NULL
,	NULL
Dilley	NULL
J	NULL
,	NULL
Levy	NULL
R	NULL
:	NULL
A	NULL
single	NULL
monoclonal	NULL
antibody	NULL
identifies	NULL
T-cell	NULL
lineage	NULL
of	NULL
childhood	NULL
lymphoid	NULL
malignancies	NULL
.	NULL

Blood	NULL
62:722	NULL
,	NULL
1983	NULL
24	NULL
.	NULL

Borowitz	NULL
MJ	NULL
,	NULL
Dowell	NULL
BL	NULL
,	NULL
Boyett	NULL
JM	NULL
,	NULL
Pullen	NULL
DJ	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Quddus	NULL
FM	NULL
,	NULL
Falletta	NULL
JM	NULL
,	NULL
Metzgar	NULL
RS	NULL
:	NULL
Clinicopathologic	NULL
aspects	NULL
of	NULL
E	NULL
rosette	NULL
negative	NULL
T	NULL
cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
:	NULL
A	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
Study	NULL
.	NULL

J	NULL
Clin	NULL
Oncol	NULL
4:170	NULL
,	NULL
1986	NULL
25	NULL
.	NULL

Abeloff	NULL
MD	NULL
,	NULL
Mangi	NULL
RJ	NULL
,	NULL
Pretlow	NULL
TG	NULL
,	NULL
Mardiney	NULL
MR	NULL
:	NULL
Isolation	NULL
of	NULL
leukemic	NULL
blasts	NULL
from	NULL
peripheral	NULL
blood	NULL
by	NULL
density	NULL
gradient	NULL
centrif-ugation	NULL
.	NULL

J	NULL
Lab	NULL
Clin	NULL
Med	NULL
75:703	NULL
,	NULL
1970	NULL
26	NULL
.	NULL

Katz	NULL
RL	NULL
,	NULL
Lukeman	NULL
JM	NULL
:	NULL
The	NULL
comparative	NULL
diagnostic	NULL
accuracy	NULL
of	NULL
cancer-cell	NULL
detection	NULL
obtained	NULL
with	NULL
Ficoll-Hypaque	NULL
gradient	NULL
separation	NULL
and	NULL
standard	NULL
centrifugation	NULL
techniques	NULL
on	NULL
body-cavity	NULL
fluids	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
74:18	NULL
,	NULL
1980	NULL
27	NULL
.	NULL

Hwang	NULL
L-Y	NULL
,	NULL
Siegelman	NULL
M	NULL
,	NULL
Davis	NULL
L	NULL
,	NULL
Oppenheimer-Marks	NULL
N	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
TALI	NULL
proto-oncogene	NULL
in	NULL
cultured	NULL
endothe-lial	NULL
cells	NULL
and	NULL
blood	NULL
vessels	NULL
of	NULL
the	NULL
spleen	NULL
.	NULL

Oncogene	NULL
8:3043	NULL
,	NULL
1993	NULL
28	NULL
.	NULL

Genescan	NULL
672	NULL
Software	NULL
,	NULL
User	NULL
's	NULL
Manual	NULL
,	NULL
Version	NULL
1.2	NULL
.	NULL

2	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
,	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Inc	NULL
,	NULL
1992	NULL
29	NULL
.	NULL

Cheng	NULL
J-T	NULL
,	NULL
Hsu	NULL
H-L	NULL
,	NULL
Hwang	NULL
L-Y	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Products	NULL
of	NULL
the	NULL
TALL	NULL
oncogene	NULL
:	NULL
basic-helix-loop-helix	NULL
proteins	NULL
phosphorylated	NULL
at	NULL
serine	NULL
residues	NULL
.	NULL

Oncogene	NULL
8:677	NULL
,	NULL
1993	NULL
30	NULL
.	NULL

Mouthon	NULL
M-A	NULL
,	NULL
Bernard	NULL
O	NULL
,	NULL
Mitjavila	NULL
M-T	NULL
,	NULL
Romeo	NULL
P-H	NULL
,	NULL
Vain-chenker	NULL
W	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
Expression	NULL
of	NULL
fal-1	NULL
and	NULL
GATA-bind-ing	NULL
proteins	NULL
during	NULL
human	NULL
hematopoiesis	NULL
.	NULL

Blood	NULL
81:647	NULL
,	NULL
1993	NULL
31	NULL
.	NULL

Pulford	NULL
K	NULL
,	NULL
Lecointe	NULL
N	NULL
,	NULL
Leroy-Viard	NULL
K	NULL
,	NULL
Jones	NULL
M	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
,	NULL
Mason	NULL
DY	NULL
:	NULL
Expression	NULL
of	NULL
TAL-1	NULL
proteins	NULL
in	NULL
human	NULL
tissues	NULL
.	NULL

Blood	NULL
85:675	NULL
,	NULL
1995	NULL
32	NULL
.	NULL

Weber	NULL
JL	NULL
:	NULL
Human	NULL
DNA	NULL
polymorphisms	NULL
based	NULL
on	NULL
length	NULL
variations	NULL
in	NULL
simple-sequence	NULL
tandem	NULL
repeats	NULL
.	NULL

Genome	NULL
Anal	NULL
1:159	NULL
,	NULL
1990	NULL
33	NULL
.	NULL

Hauge	NULL
XY	NULL
,	NULL
Litt	NULL
M	NULL
;	NULL
:	NULL
A	NULL
study	NULL
of	NULL
the	NULL
origin	NULL
of	NULL
``	NULL
shadow	NULL
bands	NULL
'	NULL
``	NULL
seen	NULL
when	NULL
typing	NULL
dinucleotide	NULL
repeat	NULL
polymorphisms	NULL
by	NULL
the	NULL
PCR	NULL
.	NULL

Hum	NULL
Mol	NULL
Genet	NULL
2:411	NULL
,	NULL
1993	NULL
34	NULL
.	NULL

Leroy-Viard	NULL
K	NULL
,	NULL
Vinit	NULL
M-A	NULL
,	NULL
Lecointe	NULL
N	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
,	NULL
Romeo	NULL
P-H	NULL
:	NULL
Distinct	NULL
DNase-I	NULL
hypersensitive	NULL
sites	NULL
are	NULL
associated	NULL
with	NULL
TAL-1	NULL
transcription	NULL
in	NULL
erythroid	NULL
and	NULL
T-cell	NULL
lines	NULL
.	NULL

Blood	NULL
84:3819	NULL
,	NULL
1994	NULL
35	NULL
.	NULL

Shima	NULL
EA	NULL
,	NULL
Beau	NULL
MML	NULL
,	NULL
McKeithan	NULL
TW	NULL
,	NULL
Minowada	NULL
J	NULL
,	NULL
Showe	NULL
LC	NULL
,	NULL
Mak	NULL
TW	NULL
,	NULL
Minden	NULL
MD	NULL
,	NULL
Rowley	NULL
JD	NULL
,	NULL
Diaz	NULL
MO	NULL
:	NULL
Gene	NULL
encoding	NULL
the	NULL
alpha	NULL
chain	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
is	NULL
moved	NULL
immediately	NULL
downstream	NULL
of	NULL
c-myc	NULL
in	NULL
a	NULL
chromosomal	NULL
8	NULL
;	NULL
14	NULL
translocation	NULL
in	NULL
a	NULL
cell	NULL
line	NULL
from	NULL
a	NULL
human	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
83:3439	NULL
,	NULL
1986	NULL
36	NULL
.	NULL

Finger	NULL
LR	NULL
,	NULL
Harvey	NULL
RC	NULL
,	NULL
Moore	NULL
RC	NULL
,	NULL
Showe	NULL
LC	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
A	NULL
common	NULL
mechanism	NULL
of	NULL
chromosomal	NULL
translocation	NULL
in	NULL
T-	NULL
and	NULL
B-cell	NULL
neoplasia	NULL
.	NULL

Science	NULL
234:982	NULL
,	NULL
1986	NULL
37	NULL
.	NULL

Hatano	NULL
M	NULL
,	NULL
Roberts	NULL
CW	NULL
,	NULL
Minden	NULL
M	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Korsmeyer	NULL
SJ	NULL
:	NULL
Deregulation	NULL
of	NULL
a	NULL
homeobox	NULL
gene	NULL
,	NULL
HOX11	NULL
,	NULL
by	NULL
the	NULL
t	NULL
(	NULL
10	NULL
;	NULL
14	NULL
)	NULL
in	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

Science	NULL
253:79	NULL
,	NULL
1991	NULL
38	NULL
.	NULL

Kennedy	NULL
MA	NULL
,	NULL
Gonzalez-Sarmiento	NULL
R	NULL
,	NULL
Kees	NULL
UR	NULL
,	NULL
Lampert	NULL
F	NULL
,	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

676	NULL
Dear	NULL
N	NULL
,	NULL
Boehm	NULL
T	NULL
,	NULL
Rabbitts	NULL
TH	NULL
:	NULL
HOX11	NULL
,	NULL
a	NULL
homeobox-containing	NULL
T-cell	NULL
oncogene	NULL
on	NULL
human	NULL
chromosome	NULL
10g24	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:8900	NULL
,	NULL
1991	NULL
39	NULL
.	NULL

Lu	NULL
M	NULL
,	NULL
Gong	NULL
ZY	NULL
,	NULL
Shen	NULL
WF	NULL
,	NULL
Ho	NULL
AD	NULL
:	NULL
The	NULL
tcl-3	NULL
proto-oncogene	NULL
altered	NULL
by	NULL
chromosomal	NULL
translocation	NULL
in	NULL
T-cell	NULL
leukemia	NULL
codes	NULL
for	NULL
a	NULL
homeobox	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
10:2905	NULL
,	NULL
1991	NULL
40	NULL
.	NULL

DubÃ©	NULL
ID	NULL
,	NULL
Kamel-Reid	NULL
S	NULL
,	NULL
Yuan	NULL
CC	NULL
,	NULL
Lu	NULL
M	NULL
,	NULL
Wu	NULL
X	NULL
,	NULL
Corpus	NULL
G	NULL
,	NULL
Raimondi	NULL
SC	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Carroll	NULL
AJ	NULL
,	NULL
Minowada	NULL
J	NULL
,	NULL
Baker	NULL
JB	NULL
:	NULL
A	NULL
novel	NULL
human	NULL
homeobox	NULL
gene	NULL
lies	NULL
at	NULL
the	NULL
chromosome	NULL
10	NULL
breakpoint	NULL
in	NULL
lymphoid	NULL
neoplasias	NULL
with	NULL
chromosomal	NULL
translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
14	NULL
)	NULL
.	NULL

Blood	NULL
78:2996	NULL
,	NULL
1991	NULL
41	NULL
.	NULL

Boehm	NULL
T	NULL
,	NULL
Baer	NULL
R	NULL
,	NULL
Lavenir	NULL
I	NULL
,	NULL
Forster	NULL
A	NULL
,	NULL
Waters	NULL
JJ	NULL
,	NULL
Nacheva	NULL
E	NULL
,	NULL
Rabbitts	NULL
TH	NULL
:	NULL
A	NULL
chromosome	NULL
translocation	NULL
t	NULL
(	NULL
11	NULL
;	NULL
14	NULL
)	NULL
in	NULL
a	NULL
human	NULL
BASH	NULL
ET	NULL
AL	NULL
leukemia	NULL
involving	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
Cy	NULL
locus	NULL
on	NULL
chromosome	NULL
14q11	NULL
and	NULL
a	NULL
transcriptionally	NULL
active	NULL
region	NULL
of	NULL
chromosome	NULL
11p15	NULL
.	NULL

EMBO	NULL
J	NULL
7:385	NULL
,	NULL
1988	NULL
42	NULL
.	NULL

McGuire	NULL
EA	NULL
,	NULL
Hockett	NULL
RD	NULL
,	NULL
Pollock	NULL
KM	NULL
,	NULL
Bartholdi	NULL
MF	NULL
,	NULL
O'Brien	NULL
SJ	NULL
,	NULL
Korsmeyer	NULL
SJ	NULL
:	NULL
The	NULL
t	NULL
(	NULL
11	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p15	NULL
;	NULL
q11	NULL
)	NULL
in	NULL
a	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
cell	NULL
line	NULL
activates	NULL
multiple	NULL
transcripts	NULL
,	NULL
including	NULL
Ttg-1	NULL
,	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
potential	NULL
zinc	NULL
finger	NULL
protein	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
9:2124	NULL
,	NULL
1989	NULL
43	NULL
.	NULL

Boehm	NULL
T	NULL
,	NULL
Foroni	NULL
L	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Perutz	NULL
MF	NULL
,	NULL
Rabbitts	NULL
TH	NULL
:	NULL
The	NULL
rhombotin	NULL
family	NULL
of	NULL
cysteine-rich	NULL
LIM-domain	NULL
oncogenes	NULL
:	NULL
Distinct	NULL
members	NULL
are	NULL
involved	NULL
in	NULL
T-cell	NULL
translocations	NULL
to	NULL
human	NULL
chromosomes	NULL
1l1p15	NULL
and	NULL
l1p13	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:4367	NULL
,	NULL
1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
--	NULL
-	NULL
Does	NULL
activation	NULL
of	NULL
the	NULL
TAL1	NULL
gene	NULL
occur	NULL
in	NULL
a	NULL
majority	NULL
of	NULL
patients	NULL
with	NULL
T-	NULL
cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
?	NULL

A	NULL
pediatric	NULL
oncology	NULL
group	NULL
study	NULL
RO	NULL
Bash	NULL
,	NULL
S	NULL
Hall	NULL
,	NULL
CF	NULL
Timmons	NULL
,	NULL
WM	NULL
Crist	NULL
,	NULL
M	NULL
Amylon	NULL
,	NULL
RG	NULL
Smith	NULL
and	NULL
R	NULL
Baer	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
t	NULL
â	NULL
f.9	NULL
'	NULL
.	NULL
'	NULL

e	NULL
>	NULL
\	NULL
/	NULL
{	NULL
Â®	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/86/2/666.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

